Aiolos	B-protein
transcription	B-protein
factor	I-protein
controls	O
cell	O
death	O
in	O
T	B-cell_type
cells	I-cell_type
by	O
regulating	O
Bcl-2	B-protein
expression	O
and	O
its	O
cellular	O
localization	O
.	O

We	O
searched	O
for	O
proteins	O
that	O
interact	O
with	O
Ras	B-protein
in	O
interleukin	B-cell_line
(	I-cell_line
IL	I-cell_line
)	I-cell_line
-2-stimulated	I-cell_line
or	I-cell_line
IL-2-deprived	I-cell_line
cells	I-cell_line
,	O
and	O
found	O
that	O
the	O
transcription	B-protein
factor	I-protein
Aiolos	B-protein
interacts	O
with	O
Ras	B-protein
.	O

The	O
Ras	B-protein
-Aiolos	B-protein
interaction	O
was	O
confirmed	O
in	O
vitro	O
and	O
in	O
vivo	O
by	O
co-immunoprecipitation	O
.	O

Indirect	O
immunofluorescence	O
shows	O
that	O
IL-2	B-protein
controls	O
the	O
cellular	O
distribution	O
of	O
Aiolos	B-protein
and	O
induces	O
its	O
tyrosine	O
phosphorylation	O
,	O
required	O
for	O
dissociation	O
from	O
Ras	B-protein
.	O

We	O
also	O
identified	O
functional	O
Aiolos-binding	B-DNA
sites	I-DNA
in	O
the	O
Bcl-2	B-DNA
promoter	I-DNA
,	O
which	O
are	O
able	O
to	O
activate	O
the	O
luciferase	B-DNA
reporter	I-DNA
gene	I-DNA
.	O

Mutation	O
of	O
Aiolos-binding	B-DNA
sites	I-DNA
within	O
the	O
Bcl-2	B-DNA
promoter	I-DNA
inhibits	O
transactivation	O
of	O
the	O
reporter	B-DNA
gene	I-DNA
luciferase	I-DNA
,	O
suggesting	O
direct	O
control	O
of	O
Bcl-2	B-protein
expression	O
by	O
Aiolos	B-protein
.	O

Co-transfection	O
experiments	O
confirm	O
that	O
Aiolos	B-protein
induces	O
Bcl-2	B-protein
expression	O
and	O
prevents	O
apoptosis	O
in	O
IL-2-deprived	B-cell_line
cells	I-cell_line
.	O

We	O
propose	O
a	O
model	O
for	O
the	O
regulation	O
of	O
Bcl-2	B-protein
expression	O
via	O
Aiolos	B-protein
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.18	NULL
No.12	NULL
pp.3419-3430	NULL
,	NULL
1999	NULL
Aiolos	NULL
transcription	NULL
factor	NULL
controls	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
regulating	NULL
Bcel-2	NULL
expression	NULL
and	NULL
its	NULL
cellular	NULL
localization	NULL
Francisco	NULL
Romero	NULL
``	NULL
,	NULL
Carlos	NULL
Martinez-A	NULL
``	NULL
,	NULL
Jacques	NULL
Camonis*	NULL
and	NULL
Angelita	NULL
Rebollo	NULL
'	NULL
``	NULL
Laboratoire	NULL
d'Oncologie	NULL
Cellulaire	NULL
et	NULL
Moleculaire	NULL
,	NULL
INSERM	NULL
U363	NULL
,	NULL
Hopital	NULL
Cochin	NULL
,	NULL
27	NULL
rue	NULL
du	NULL
Faubourg	NULL
Saint-Jacques	NULL
,	NULL
F-75014	NULL
Paris	NULL
,	NULL
France	NULL
,	NULL
*Department	NULL
of	NULL
Immunology	NULL
and	NULL
Oncology	NULL
,	NULL
Centro	NULL
Nacional	NULL
de	NULL
Biotecnologia	NULL
,	NULL
Campus	NULL
de	NULL
Cantoblanco	NULL
UAM	NULL
,	NULL
E-28049	NULL
Madrid	NULL
,	NULL
Spain	NULL
and	NULL
``	NULL
Institut	NULL
Curie	NULL
,	NULL
INSERM	NULL
U248	NULL
,	NULL
26	NULL
rue	NULL
d'Ulm	NULL
,	NULL
F-75248	NULL
,	NULL
Paris	NULL
Cedex	NULL
05	NULL
,	NULL
France	NULL
*Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Facultad	NULL
de	NULL
Biologia	NULL
,	NULL
Apdo	NULL
.	NULL

1095	NULL
,	NULL
E-41080	NULL
Seville	NULL
,	NULL
Spain	NULL
3Corresponding	NULL
author	NULL
e-mail	NULL
:	NULL
arebollo	NULL
@	NULL
cnb.uam.es	NULL
We	NULL
searched	NULL
for	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
Ras	NULL
in	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
and	NULL
found	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
Aiolos	NULL
interacts	NULL
with	NULL
Ras	NULL
.	NULL

The	NULL
Ras-Aiolos	NULL
interaction	NULL
was	NULL
confirmed	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
by	NULL
co-immunoprecipitation	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
shows	NULL
that	NULL
IL-2	NULL
controls	NULL
the	NULL
cellular	NULL
distribution	NULL
of	NULL
Aiolos	NULL
and	NULL
induces	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
required	NULL
for	NULL
dissociation	NULL
from	NULL
Ras	NULL
.	NULL

We	NULL
also	NULL
identified	NULL
functional	NULL
Aiolos-binding	NULL
sites	NULL
in	NULL
the	NULL
Bcl-2	NULL
promoter	NULL
,	NULL
which	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Mutation	NULL
of	NULL
Aiolos-binding	NULL
sites	NULL
within	NULL
the	NULL
Bel-2	NULL
promoter	NULL
inhibits	NULL
transactivation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
luciferase	NULL
,	NULL
suggesting	NULL
direct	NULL
control	NULL
of	NULL
Bel-2	NULL
expression	NULL
by	NULL
Aiolos	NULL
.	NULL

Co-transfection	NULL
experiments	NULL
confirm	NULL
that	NULL
Aiolos	NULL
induces	NULL
Bcl-2	NULL
expression	NULL
and	NULL
prevents	NULL
apoptosis	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

We	NULL
propose	NULL
a	NULL
model	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
Bel-2	NULL
expression	NULL
via	NULL
Aiolos	NULL
.	NULL

Keywords	NULL
:	NULL
Aiolos/apoptosis/Bcl-2/phosphorylation	NULL
Introduction	NULL
The	NULL
Aiolos	NULL
transcription	NULL
factor	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
homologue	NULL
of	NULL
the	NULL
Ikaros	NULL
transcription	NULL
factor	NULL
,	NULL
whose	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
lymphoid	NULL
lineage	NULL
.	NULL

Aiolos	NULL
homodimers	NULL
are	NULL
potent	NULL
transcriptional	NULL
activators	NULL
,	NULL
whereas	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
Aiolos-Ikaros	NULL
heterodimers	NULL
ranges	NULL
from	NULL
low	NULL
to	NULL
undetectable	NULL
.	NULL

Aiolos	NULL
was	NULL
first	NULL
described	NULL
in	NULL
committed	NULL
lymphoid	NULL
progenitors	NULL
,	NULL
and	NULL
is	NULL
strongly	NULL
up-regulated	NULL
as	NULL
these	NULL
progenitors	NULL
become	NULL
restricted	NULL
into	NULL
T-and	NULL
B-lymphoid	NULL
pathways	NULL
(	NULL
Morgan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Aiolos	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
as	NULL
a	NULL
regulator	NULL
of	NULL
B-cell	NULL
differenti-ation	NULL
,	NULL
proliferation	NULL
and	NULL
maturation	NULL
to	NULL
an	NULL
effector	NULL
state	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
interplay	NULL
between	NULL
these	NULL
proteins	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
is	NULL
further	NULL
complicated	NULL
by	NULL
additional	NULL
Ikaros	NULL
isoforms	NULL
or	NULL
by	NULL
other	NULL
proteins	NULL
that	NULL
can	NULL
sequester	NULL
either	NULL
Ikaros	NULL
or	NULL
Aiolos	NULL
in	NULL
transcriptionally	NULL
inert	NULL
complexes	NULL
(	NULL
Morgan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Ras	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
.	NULL

Their	NULL
function	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
©	NULL
European	NULL
Molecular	NULL
Biology	NULL
Organization	NULL
GTP-GDP	NULL
cycle	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
classes	NULL
of	NULL
regulatory	NULL
proteins	NULL
(	NULL
Boguski	NULL
and	NULL
McCormick	NULL
,	NULL
1993	NULL
;	NULL
McCormick	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
Ras	NULL
proteins	NULL
in	NULL
cell	NULL
proliferation	NULL
is	NULL
best	NULL
exemplified	NULL
by	NULL
the	NULL
high	NULL
frequency	NULL
of	NULL
mutated	NULL
Ras	NULL
genes	NULL
in	NULL
neoplasia	NULL
.	NULL

Ras	NULL
acts	NULL
at	NULL
several	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
is	NULL
required	NULL
soon	NULL
after	NULL
the	NULL
release	NULL
of	NULL
cells	NULL
from	NULL
quiescence	NULL
(	NULL
Dobrowolski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Pan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

There	NULL
are	NULL
two	NULL
peaks	NULL
of	NULL
Ras	NULL
activation	NULL
before	NULL
the	NULL
S	NULL
phase	NULL
;	NULL
the	NULL
earlier	NULL
one	NULL
is	NULL
growth-factor	NULL
triggered	NULL
,	NULL
whereas	NULL
the	NULL
second	NULL
,	NULL
which	NULL
is	NULL
stronger	NULL
than	NULL
the	NULL
first	NULL
,	NULL
is	NULL
growth-factor	NULL
independent	NULL
(	NULL
Taylor	NULL
and	NULL
Shalloway	NULL
,	NULL
1996	NULL
;	NULL
Winston	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Several	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
Ras	NULL
activation	NULL
can	NULL
promote	NULL
either	NULL
proliferation	NULL
or	NULL
apoptosis	NULL
(	NULL
Ferrari	NULL
and	NULL
Greene	NULL
,	NULL
1994	NULL
;	NULL
Gulbins	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
,	NULL
1997	NULL
,	NULL
1998b	NULL
;	NULL
Wilson	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Ras	NULL
mediates	NULL
the	NULL
apoptotic	NULL
effect	NULL
triggered	NULL
by	NULL
deprivation	NULL
of	NULL
growth	NULL
factors	NULL
such	NULL
as	NULL
serum	NULL
,	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-3	NULL
or	NULL
IL-2	NULL
(	NULL
Reed	NULL
,	NULL
1994	NULL
;	NULL
Consiglio	NULL
and	NULL
Formisano	NULL
,	NULL
1995	NULL
;	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

According	NULL
to	NULL
the	NULL
pro-	NULL
or	NULL
anti-apoptotic	NULL
role	NULL
of	NULL
Ras	NULL
,	NULL
we	NULL
can	NULL
propose	NULL
that	NULL
two	NULL
different	NULL
Ras-mediated	NULL
pathways	NULL
may	NULL
be	NULL
triggered	NULL
by	NULL
an	NULL
external	NULL
stimulus	NULL
,	NULL
one	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
the	NULL
other	NULL
in	NULL
apoptosis	NULL
.	NULL

Alternatively	NULL
,	NULL
one	NULL
Ras-mediated	NULL
pathway	NULL
may	NULL
trigger	NULL
either	NULL
proliferation	NULL
or	NULL
apoptosis	NULL
,	NULL
depending	NULL
on	NULL
external	NULL
signals	NULL
and/	NULL
or	NULL
associated	NULL
pathways	NULL
.	NULL

Apoptotic	NULL
cell	NULL
death	NULL
is	NULL
a	NULL
process	NULL
ultimately	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
endogenous	NULL
nucleases	NULL
that	NULL
promote	NULL
internucleosomal	NULL
DNA	NULL
-	NULL
degradation	NULL
(	NULL
Wyllie	NULL
,	NULL
1980	NULL
)	NULL
.	NULL

Apoptosis	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
growth-factor	NULL
deprivation	NULL
(	NULL
Duke	NULL
and	NULL
Cohen	NULL
,	NULL
1986	NULL
;	NULL
Nufiez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
signalling	NULL
via	NULL
surface	NULL
receptors	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Baumon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
and	NULL
exposure	NULL
to	NULL
drugs	NULL
(	NULL
Zubiaga	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Many	NULL
components	NULL
of	NULL
the	NULL
machinery	NULL
that	NULL
regulates	NULL
and	NULL
executes	NULL
programmed	NULL
cell	NULL
death	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
Nagata	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Numerous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
Bcel-2	NULL
is	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
cell	NULL
survival	NULL
,	NULL
protecting	NULL
various	NULL
cell	NULL
types	NULL
from	NULL
death	NULL
induced	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
,	NULL
heat	NULL
shock	NULL
and	NULL
viral	NULL
agents	NULL
(	NULL
Reed	NULL
,	NULL
1994	NULL
;	NULL
Park	NULL
and	NULL
Hockembery	NULL
,	NULL
1996	NULL
;	NULL
White	NULL
,	NULL
1996	NULL
;	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
but	NULL
the	NULL
biochemical	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
protein	NULL
prevents	NULL
apoptosis	NULL
remains	NULL
enigmatic	NULL
(	NULL
Yang	NULL
and	NULL
Korsmeyer	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Bcel-2	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
interact	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Ras	NULL
superfamily	NULL
of	NULL
proteins	NULL
(	NULL
Fernandez-Sarabia	NULL
and	NULL
Bischoff	NULL
,	NULL
1993	NULL
;	NULL
Chen	NULL
and	NULL
Faller	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

IL-2-dependent	NULL
T	NULL
cells	NULL
die	NULL
by	NULL
apoptosis	NULL
after	NULL
IL-2	NULL
withdrawal	NULL
,	NULL
and	NULL
transfection	NULL
of	NULL
Bcel-2	NULL
promotes	NULL
survival	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
Broome	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Minami	NULL
and	NULL
Taniguchi	NULL
,	NULL
1995	NULL
;	NULL
Miyazaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Bcel-2	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
IL-2-dependent	NULL
murine	NULL
T-cell	NULL
line	NULL
TS1oB	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
decreases	NULL
when	NULL
cells	NULL
are	NULL
deprived	NULL
of	NULL
IL-2	NULL
.	NULL

Overexpression	NULL
of	NULL
Bcel-2	NULL
in	NULL
these	NULL
cells	NULL
extends	NULL
their	NULL
survival	NULL
time	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
Ras	NULL
pathway	NULL
induces	NULL
expression	NULL
3419	NULL
FRomero	NULL
et	NULL
al	NULL
.	NULL

of	NULL
genes	NULL
necessary	NULL
for	NULL
cell	NULL
survival	NULL
;	NULL
accordingly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
Ras	NULL
signalling	NULL
pathway	NULL
induces	NULL
and	NULL
regulates	NULL
Bcel-2	NULL
expression	NULL
(	NULL
Kinoshita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
used	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
method	NULL
to	NULL
identify	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
Ras	NULL
in	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
Aiolos	NULL
was	NULL
identified	NULL
as	NULL
interacting	NULL
with	NULL
Ras	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
were	NULL
confirmed	NULL
by	NULL
a	NULL
genetic	NULL
approach	NULL
,	NULL
by	NULL
co-immunoprecipitation	NULL
and	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
.	NULL

They	NULL
suggest	NULL
a	NULL
physiological	NULL
role	NULL
for	NULL
a	NULL
Ras-Aiolos	NULL
interaction	NULL
in	NULL
the	NULL
control	NULL
of	NULL
Bcel-2	NULL
expression	NULL
.	NULL

They	NULL
also	NULL
indicate	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interact	NULL
only	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
,	NULL
and	NULL
require	NULL
reassessment	NULL
of	NULL
the	NULL
meaning	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
Ras	NULL
is	NULL
inactive	NULL
in	NULL
its	NULL
GDP-bound	NULL
form	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
these	NULL
findings	NULL
is	NULL
discussed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
apoptosis	NULL
.	NULL

Results	NULL
Isolation	NULL
of	NULL
Ras-interacting	NULL
proteins	NULL
in	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
TS1o0f	NULL
cells	NULL
We	NULL
have	NULL
described	NULL
how	NULL
Ras	NULL
activation	NULL
leads	NULL
to	NULL
cell	NULL
proliferation	NULL
or	NULL
apoptotic	NULL
cell	NULL
death	NULL
after	NULL
IL-2	NULL
stimulation	NULL
or	NULL
IL-2	NULL
deprivation	NULL
of	NULL
the	NULL
murine	NULL
cell	NULL
line	NULL
,	NULL
respectively	NULL
(	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
two	NULL
different	NULL
Ras-mediated	NULL
pathways	NULL
are	NULL
triggered	NULL
by	NULL
an	NULL
external	NULL
stimulus	NULL
,	NULL
one	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
the	NULL
other	NULL
in	NULL
apoptosis	NULL
using	NULL
different	NULL
effectors	NULL
,	NULL
or	NULL
alternatively	NULL
,	NULL
whether	NULL
one	NULL
Ras-mediated	NULL
pathway	NULL
might	NULL
trigger	NULL
either	NULL
cell	NULL
proliferation	NULL
or	NULL
apoptosis	NULL
.	NULL

To	NULL
identify	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
Ras	NULL
in	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
Ras	NULL
wild-type	NULL
was	NULL
used	NULL
as	NULL
bait	NULL
to	NULL
screen	NULL
,	NULL
using	NULL
the	NULL
two-hybrid	NULL
method	NULL
,	NULL
cDNA	NULL
libraries	NULL
made	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
TS1afB	NULL
cells	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
one	NULL
specific	NULL
clone	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
isolated	NULL
from	NULL
the	NULL
cDNA	NULL
library	NULL
of	NULL
IL-2-deprived	NULL
cells	NULL
showed	NULL
a	NULL
100	NULL
%	NULL
match	NULL
to	NULL
a	NULL
partial	NULL
cDNA	NULL
encoding	NULL
the	NULL
proximal	NULL
C-terminal	NULL
region	NULL
of	NULL
the	NULL
Aiolos	NULL
murine	NULL
transcription	NULL
factor	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

cDNA	NULL
encoding	NULL
full-length	NULL
Aiolos	NULL
was	NULL
cloned	NULL
in	NULL
pLex10	NULL
and	NULL
tested	NULL
for	NULL
interaction	NULL
with	NULL
Ras	NULL
wild-type	NULL
;	NULL
both	NULL
the	NULL
full-length	NULL
protein	NULL
and	NULL
the	NULL
truncated	NULL
form	NULL
isolated	NULL
during	NULL
screening	NULL
,	NULL
interact	NULL
with	NULL
Ras	NULL
.	NULL

Aiolos	NULL
was	NULL
then	NULL
tested	NULL
for	NULL
interaction	NULL
with	NULL
Ras	NULL
mutants	NULL
.	NULL

Aiolos	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
N17	NULL
or	NULL
V12	NULL
Ras	NULL
mutants	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
protein	NULL
probably	NULL
requires	NULL
the	NULL
GDP	NULL
form	NULL
of	NULL
Ras	NULL
for	NULL
interaction	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Other	NULL
related	NULL
members	NULL
of	NULL
the	NULL
Ras	NULL
family	NULL
,	NULL
such	NULL
as	NULL
Racl	NULL
,	NULL
RacZ	NULL
,	NULL
Rap1lA	NULL
or	NULL
RalB	NULL
,	NULL
do	NULL
not	NULL
interact	NULL
with	NULL
Aiolos	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
Ras	NULL
wild-type-Aiolos	NULL
interaction	NULL
is	NULL
specific	NULL
for	NULL
Ras	NULL
.	NULL

Binding	NULL
of	NULL
Aiolos	NULL
and	NULL
Ras	NULL
wild-type	NULL
probably	NULL
occurs	NULL
through	NULL
the	NULL
effector	NULL
domain	NULL
of	NULL
Ras	NULL
,	NULL
since	NULL
the	NULL
Ras	NULL
effector	NULL
domain	NULL
mutant	NULL
L35R37	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
Aiolos	NULL
.	NULL

Association	NULL
of	NULL
Ras	NULL
wild-type	NULL
and	NULL
Aiolos	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
To	NULL
validate	NULL
the	NULL
results	NULL
obtained	NULL
using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
Ras	NULL
wild-type	NULL
and	NULL
Aiolos	NULL
was	NULL
studied	NULL
in	NULL
intact	NULL
cells	NULL
by	NULL
co-immunoprecipitation	NULL
using	NULL
Aiolos-	NULL
and	NULL
Ras-specific	NULL
antibodies	NULL
.	NULL

We	NULL
performed	NULL
reciprocal	NULL
co-immunoprecipitation	NULL
experiments	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
under	NULL
IL-2	NULL
stimulation	NULL
or	NULL
deprivation	NULL
conditions	NULL
in	NULL
TS1aB	NULL
cells	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

High	NULL
Ras	NULL
levels	NULL
3420	NULL
2-HYBRID	NULL
2-HYBRID	NULL
DB	NULL
AD	NULL
DB	NULL
AD	NULL
rus	NULL
wi	NULL
atoros*	NULL
ity	NULL
$	NULL
t	NULL
-	NULL
(	NULL
2D	NULL
tats	NULL
Ras	NULL
wt	NULL
Aiolos	NULL
Ras	NULL
wi	NULL
=	NULL
--	NULL
th	NULL
lh	NULL
age	NULL
#	NULL
=	NULL
Aiolos	NULL
Ras	NULL
wi	NULL
Raf	NULL
.	NULL

~	NULL
RasV12	NULL
Aiolos*	NULL
RasN17	NULL
-	NULL
Ajoles®	NULL
s	NULL
--	NULL
RalB	NULL
wt	NULL
Aijolos	NULL
Reci	NULL
wt	NULL
Ajolos	NULL
paly	NULL
``	NULL
~A	NULL
*	NULL
Rac	NULL
wt	NULL
Raplawt	NULL
Ajiolos	NULL
|_	NULL
coe	NULL
-	NULL
«	NULL
Weel	NULL
_	NULL
ResL3SR37	NULL
Atolos	NULL
NH2	NULL
COOH	NULL
Binding	NULL
Activation	NULL
Dimerization	NULL
e	NULL
I	NULL
o	NULL
IL	NULL
__	NULL
T	NULL
_	NULL
Domain	NULL
Domain	NULL
Domain	NULL
AIOLOS*	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Interaction	NULL
of	NULL
wild-type	NULL
Ras	NULL
with	NULL
Aiolos	NULL
in	NULL
the	NULL
two-hybrid	NULL
system	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Interaction	NULL
of	NULL
wild-type	NULL
Ras	NULL
with	NULL
Aiolos	NULL
.	NULL

The	NULL
S.cerevisice	NULL
L40	NULL
reporter	NULL
strain	NULL
was	NULL
co-transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
the	NULL
two-hybrid	NULL
proteins	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
lacZ	NULL
expression	NULL
(	NULL
blue	NULL
patches	NULL
)	NULL
.	NULL

There	NULL
are	NULL
two	NULL
patches	NULL
for	NULL
each	NULL
strain	NULL
and	NULL
each	NULL
patch	NULL
represents	NULL
an	NULL
independent	NULL
transformant	NULL
.	NULL

L40	NULL
carrying	NULL
wild-type	NULL
Ras	NULL
and	NULL
Raf	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

DB	NULL
,	NULL
fusion	NULL
with	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
Lex10	NULL
.	NULL

AD	NULL
,	NULL
fusion	NULL
with	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
Gal4	NULL
.	NULL

Interaction	NULL
of	NULL
full-length	NULL
Aiolos	NULL
with	NULL
other	NULL
Ras	NULL
superfamily	NULL
members	NULL
is	NULL
also	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
full-length	NULL
Aiolos	NULL
and	NULL
the	NULL
positive	NULL
clone	NULL
derived	NULL
from	NULL
Aiolos	NULL
(	NULL
marked	NULL
as	NULL
Aiolos®	NULL
)	NULL
obtained	NULL
upon	NULL
screening	NULL
of	NULL
the	NULL
cDNA	NULL
library	NULL
of	NULL
IL-2-deprived	NULL
TS1	NULL
@	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
different	NULL
Aiolos	NULL
domains	NULL
are	NULL
shown	NULL
.	NULL

were	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
in	NULL
anti-Aiolos	NULL
immunoprecipitates	NULL
of	NULL
cells	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
amount	NULL
of	NULL
Ras	NULL
detected	NULL
in	NULL
cytoplasm	NULL
decreased	NULL
slightly	NULL
in	NULL
12	NULL
h	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
with	NULL
minimum	NULL
Ras	NULL
levels	NULL
detected	NULL
in	NULL
cytoplasmic	NULL
Aiolos	NULL
immunoprecipitates	NULL
of	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

Reprobing	NULL
the	NULL
membrane	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
shows	NULL
different	NULL
amounts	NULL
of	NULL
Aiolos	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
IL-2-stimulated	NULL
(	NULL
low	NULL
levels	NULL
)	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
high	NULL
levels	NULL
)	NULL
.	NULL

In	NULL
reciprocal	NULL
experiments	NULL
,	NULL
high	NULL
Aiolos	NULL
levels	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
in	NULL
anti-Ras	NULL
immunoprecipitates	NULL
from	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
24	NULL
h	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
cytoplasmic	NULL
Aiolos	NULL
detected	NULL
decreased	NULL
after	NULL
12h	NULL
of	NULL
IL-2	NULL
deprivation	NULL
,	NULL
reaching	NULL
the	NULL
minimum	NULL
level	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

The	NULL
Ras	NULL
protein	NULL
level	NULL
did	NULL
not	NULL
diminish	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
probing	NULL
the	NULL
membrane	NULL
with	NULL
anti-Ras	NULL
antibody	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
Ras	NULL
interacts	NULL
with	NULL
Aiolos	NULL
in	NULL
vivo	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
is	NULL
specific	NULL
,	NULL
since	NULL
immunoprecipitation	NULL
of	NULL
cytoplasmic	NULL
lysates	NULL
with	NULL
an	NULL
irrelevant	NULL
antibody	NULL
(	NULL
anti-IL-2	NULL
)	NULL
detects	NULL
neither	NULL
Aiolos	NULL
nor	NULL
Ras	NULL
.	NULL

Co-immunoprecipitation	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
isolated	NULL
by	NULL
digitonin	NULL
lysis	NULL
of	NULL
the	NULL
cells	NULL
showed	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
reveal	NULL
that	NULL
Ras	NULL
complexed	NULL
to	NULL
Aiolos	NULL
is	NULL
recovered	NULL
from	NULL
cells	NULL
,	NULL
confirming	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
the	NULL
two-hybrid	NULL
system	NULL
.	NULL

Total	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
show	NULL
the	NULL
same	NULL
level	NULL
of	NULL
Aiolos	NULL
expression	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
levels	NULL
detected	NULL
in	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
;	NULL
this	NULL
suggests	NULL
a	NULL
distinct	NULL
cellular	NULL
distribution	NULL
of	NULL
Aiolos	NULL
rather	NULL
than	NULL
differences	NULL
in	NULL
the	NULL
total	NULL
protein	NULL
level	NULL
.	NULL

We	NULL
addressed	NULL
this	NULL
question	NULL
a-	NULL
}	NULL
A	NULL
24	NULL
h	NULL
12	NULL
h	NULL
5	NULL
£	NULL
D	NULL
IL-2	NULL
+o	NULL
-	NULL
+0	NULL
-	NULL
E	NULL
kDa	NULL
IP	NULL
Aiolos	NULL
(	NULL
tl	NULL
wB	NULL
Ras	NULL
«	NULL
#	NULL
21	NULL
IP	NULL
Aiolos	NULL
y	NULL
A9	NULL
``	NULL
,	NULL
«	NULL
ep	NULL
56	NULL
wB	NULL
Aiolos	NULL
nuke	NULL
IP	NULL
Ras	NULL
wB	NULL
Aiolos	NULL
”	NULL
ﬁl-	NULL
yp	NULL
56	NULL
IP	NULL
Ras	NULL
cums	NULL
omm	NULL
«	NULL
mmm	NULL
.	NULL

21	NULL
WB	NULL
Ras	NULL
-e	NULL
j	NULL
B	NULL
12	NULL
h	NULL
24	NULL
h	NULL
IL-2	NULL
+	NULL
-	NULL
e	NULL
Aiolos	NULL
56	NULL
c	NULL
N	NULL
C	NULL
12	NULL
h	NULL
24	NULL
h	NULL
24	NULL
h	NULL
IL-2	NULL
y	NULL
:	NULL
=	NULL
+	NULL
-	NULL
es	NULL
kDa	NULL
a-Aiolos	NULL
AR	NULL
rete	NULL
HUEY	NULL
-	NULL
vac	NULL
w.	NULL
on	NULL
...	NULL
...	NULL
cations	NULL
56	NULL
p	NULL
R	NULL
a-Ras	NULL
@	NULL
21	NULL
=	NULL
--	NULL
&	NULL
1	NULL
u-	NULL
»	NULL
a-Histones	NULL
tun	NULL
cme	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interaction	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
by	NULL
analysing	NULL
whether	NULL
Aiolos	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

Aiolos	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
IL-2-stimulated	NULL
cells	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
Aiolos	NULL
decreased	NULL
with	NULL
the	NULL
length	NULL
of	NULL
the	NULL
IL-2	NULL
deprivation	NULL
period	NULL
,	NULL
reaching	NULL
minimum	NULL
levels	NULL
at	NULL
24	NULL
h	NULL
of	NULL
IL-2	NULL
deprivation	NULL
.	NULL

This	NULL
deprivation	NULL
period	NULL
corresponds	NULL
to	NULL
the	NULL
maximum	NULL
Aiolos	NULL
level	NULL
detected	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
suggesting	NULL
the	NULL
trafficking	NULL
of	NULL
Aiolos	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

As	NULL
internal	NULL
control	NULL
of	NULL
protein	NULL
fractionation	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
pan-Ras	NULL
(	NULL
cytoplasmic	NULL
marker	NULL
)	NULL
and	NULL
anti-histone	NULL
antibodies	NULL
(	NULL
nuclear	NULL
marker	NULL
)	NULL
.	NULL

The	NULL
Ras-Aiolos	NULL
interaction	NULL
was	NULL
also	NULL
studied	NULL
in	NULL
in	NULL
vitro	NULL
binding	NULL
experiments	NULL
.	NULL

Aiolos	NULL
was	NULL
produced	NULL
as	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
protein	NULL
and	NULL
purified	NULL
on	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

The	NULL
Vav	NULL
SH2	NULL
domain	NULL
fused	NULL
to	NULL
GST	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Cytoplasmic	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
GST-Aiolos	NULL
and	NULL
with	NULL
GST-Vav	NULL
SH2	NULL
and	NULL
,	NULL
after	NULL
several	NULL
washing	NULL
steps	NULL
,	NULL
proteins	NULL
were	NULL
resolved	NULL
in	NULL
SDS-PAGE	NULL
and	NULL
the	NULL
blot	NULL
developed	NULL
with	NULL
anti-Ras	NULL
antibody	NULL
.	NULL

Figure	NULL
3A	NULL
shows	NULL
that	NULL
Ras	NULL
interacts	NULL
with	NULL
the	NULL
GST-Aiolos	NULL
fusion	NULL
protein	NULL
,	NULL
whereas	NULL
there	NULL
is	NULL
no	NULL
interaction	NULL
with	NULL
GST	NULL
alone	NULL
or	NULL
with	NULL
GST-Vav	NULL
.	NULL

In	NULL
reciprocal	NULL
experiments	NULL
,	NULL
GST-Ras	NULL
proteins	NULL
were	NULL
purified	NULL
on	NULL
glutathione-agarose	NULL
beads	NULL
,	NULL
and	NULL
the	NULL
SH2/Vav	NULL
construct	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

The	NULL
GST-Ras	NULL
proteins	NULL
were	NULL
loaded	NULL
with	NULL
guanine	NULL
nucleotides	NULL
by	NULL
incubation	NULL
with	NULL
GDP	NULL
or	NULL
GTP-yS	NULL
.	NULL

Aiolos	NULL
interacts	NULL
with	NULL
GST-Ras/GDP	NULL
in	NULL
cytoplasmic	NULL
lysates	NULL
of	NULL
IL-2-deprived	NULL
or	NULL
IL-2-stimulated	NULL
cells	NULL
,	NULL
although	NULL
in	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
Aiolos	NULL
that	NULL
interacts	NULL
with	NULL
GST-Ras/GDP	NULL
is	NULL
greatly	NULL
reduced	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
two-hybrid	NULL
results	NULL
obtained	NULL
using	NULL
Ras	NULL
alleles	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
,	NULL
in	NULL
which	NULL
Aiolos	NULL
interacts	NULL
with	NULL
the	NULL
GDP	NULL
form	NULL
of	NULL
Ras	NULL
.	NULL

To	NULL
confirm	NULL
Aiolos	NULL
interaction	NULL
with	NULL
the	NULL
GDP	NULL
Ras	NULL
form	NULL
,	NULL
GST-Ras	NULL
proteins	NULL
were	NULL
loaded	NULL
with	NULL
the	NULL
nonhydrolysable	NULL
GTP	NULL
analogue	NULL
GTP-yS	NULL
.	NULL

Aiolos	NULL
interacts	NULL
weakly	NULL
with	NULL
Ras-GTP-yS	NULL
in	NULL
cytoplasmic	NULL
lysates	NULL
of	NULL
IL-2-stimulated	NULL
cells	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
,	NULL
and	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Reciprocal	NULL
co-immunoprecipitation	NULL
of	NULL
wild-type	NULL
Ras	NULL
and	NULL
Aiolos	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cytoplasmic	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
1X10	NULL
``	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Aiolos	NULL
or	NULL
irrelevant	NULL
antibody	NULL
(	NULL
anti-IL-2	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
pan-Ras	NULL
antibody	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
.	NULL

Similarly	NULL
,	NULL
cytoplasmic	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
pan-Ras	NULL
,	NULL
washed	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-Aiolos	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
pan-Ras	NULL
.	NULL

Protein	NULL
bands	NULL
were	NULL
detected	NULL
using	NULL
the	NULL
ECL	NULL
system	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Total	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
5X10°	NULL
)	NULL
were	NULL
resolved	NULL
in	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
probed	NULL
with	NULL
anti-Aiolos	NULL
,	NULL
and	NULL
protein	NULL
bands	NULL
detected	NULL
as	NULL
above	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
shown	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
2X10	NULL
``	NULL
)	NULL
.	NULL

After	NULL
quantification	NULL
,	NULL
20	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
resolved	NULL
in	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
immunoblotted	NULL
sequentially	NULL
with	NULL
anti-Aiolos	NULL
,	NULL
pan-Ras	NULL
(	NULL
cytoplasmic	NULL
marker	NULL
)	NULL
and	NULL
anti-histone	NULL
H1	NULL
,	NULL
H2a	NULL
,	NULL
H2b	NULL
,	NULL
H3	NULL
and	NULL
H4	NULL
antibodies	NULL
(	NULL
nuclear	NULL
marker	NULL
)	NULL
.	NULL

As	NULL
internal	NULL
control	NULL
of	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
fractionation	NULL
,	NULL
cytoplasmic	NULL
proteins	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
were	NULL
used	NULL
and	NULL
also	NULL
blotted	NULL
with	NULL
anti-Aiolos	NULL
,	NULL
pan-Ras	NULL
and	NULL
anti-histone	NULL
antibodies	NULL
.	NULL

Protein	NULL
bands	NULL
were	NULL
detected	NULL
as	NULL
above	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

3421	NULL
FRomero	NULL
et	NULL
al	NULL
.	NULL

A	NULL
GST-Yav/SH2	NULL
GST-Yav/SH2	NULL
GST-Aiolos	NULL
GST-Aiolos	NULL
GST	NULL
IL-2	NULL
+	NULL
I	NULL
#	NULL
I	NULL
I	NULL
kDa	NULL
Ras	NULL
t	NULL
21	NULL
GST-Ras/GDP	NULL
GST-Ras/GDP	NULL
GST-Yav/SH2	NULL
GST-Yav/SH2	NULL
GST	NULL
IL-2	NULL
#	NULL
I	NULL
+	NULL
|	NULL
I	NULL
kDa	NULL
Aiolos	NULL
56	NULL
,	NULL
E	NULL
C	NULL
GST-Ras/GTP-y-	NULL
$	NULL
GST-Ras/GTP-y-	NULL
$	NULL
GST-Yav/SH2	NULL
GST-Yav/SH2	NULL
GST	NULL
1	NULL
[	NULL
+	NULL
|	NULL
+	NULL
I	NULL
I	NULL
kDa	NULL
Aiolos	NULL
56	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Aiolos	NULL
interacts	NULL
with	NULL
Ras	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
GST-Aiolos	NULL
fusion	NULL
protein	NULL
was	NULL
induced	NULL
by	NULL
IPTG	NULL
addition	NULL
and	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
bacterial	NULL
lysates	NULL
by	NULL
affinity	NULL
chromatography	NULL
with	NULL
glutathione-agarose	NULL
beads	NULL
and	NULL
incubated	NULL
with	NULL
cytoplasmic	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
7X	NULL
10°	NULL
)	NULL
.	NULL

After	NULL
several	NULL
washing	NULL
steps	NULL
,	NULL
eluted	NULL
proteins	NULL
were	NULL
resolved	NULL
in	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
immunoblotted	NULL
with	NULL
pan-Ras	NULL
.	NULL

Protein	NULL
bands	NULL
were	NULL
detected	NULL
using	NULL
the	NULL
ECL	NULL
system	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Similarly	NULL
,	NULL
GST-Ras/GDP	NULL
(	NULL
B	NULL
)	NULL
or	NULL
GST-Ras/GTP-yS	NULL
(	NULL
C	NULL
)	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
cytoplasmic	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
10°	NULL
)	NULL
.	NULL

Eluted	NULL
proteins	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
,	NULL
and	NULL
protein	NULL
bands	NULL
detected	NULL
using	NULL
ECL	NULL
or	NULL
ECL	NULL
Plus	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

this	NULL
interaction	NULL
in	NULL
cytoplasmic	NULL
lysates	NULL
of	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
Aiolos	NULL
interaction	NULL
with	NULL
GST-SH2/Vav	NULL
.	NULL

Aiolos	NULL
mRNA	NULL
expression	NULL
is	NULL
not	NULL
modified	NULL
in	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
It	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
IL-2	NULL
could	NULL
modulate	NULL
Aiolos	NULL
mRNA	NULL
levels	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
isolated	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
electrophoresed	NULL
and	NULL
hybridized	NULL
with	NULL
an	NULL
Aiolos-specific	NULL
probe	NULL
that	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Ikaros	NULL
.	NULL

The	NULL
result	NULL
shows	NULL
that	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
does	NULL
not	NULL
modulate	NULL
the	NULL
Aiolos	NULL
3422	NULL
IL-2	NULL
~IL-2	NULL
Kb	NULL
AIOLOS	NULL
..	NULL
4.4	NULL
285	NULL
tn	NULL
we	NULL
185	NULL
tuccusts	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Aiolos	NULL
mRNA	NULL
expression	NULL
in	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
20	NULL
%	NULL
10°	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
24	NULL
h	NULL
)	NULL
.	NULL

RNA	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
with	NULL
formaldehyde	NULL
,	NULL
blotted	NULL
and	NULL
hybridized	NULL
in	NULL
high	NULL
stringency	NULL
conditions	NULL
with	NULL
a	NULL
°°P-labelled	NULL
300	NULL
bp	NULL
DNA	NULL
probe	NULL
that	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Ikaros	NULL
.	NULL

After	NULL
elution	NULL
of	NULL
this	NULL
probe	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
rehybridized	NULL
with	NULL
a	NULL
°P-labelled	NULL
600	NULL
bp	NULL
probe	NULL
for	NULL
B-actin	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
labelled	NULL
by	NULL
random	NULL
priming	NULL
.	NULL

Both	NULL
288	NULL
and	NULL
188	NULL
are	NULL
also	NULL
shown	NULL
to	NULL
estimate	NULL
RNA	NULL
levels	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

mRNA	NULL
level	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

The	NULL
B-actin	NULL
levels	NULL
,	NULL
as	NULL
well	NULL
as	NULL
288	NULL
and	NULL
188	NULL
mRNAs	NULL
,	NULL
were	NULL
similar	NULL
in	NULL
both	NULL
cases	NULL
.	NULL

IL-2	NULL
controls	NULL
the	NULL
cellular	NULL
localization	NULL
of	NULL
Aiolos	NULL
As	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
fractionation	NULL
procedures	NULL
can	NULL
lead	NULL
to	NULL
protein	NULL
leakage	NULL
or	NULL
contamination	NULL
from	NULL
one	NULL
compartment	NULL
to	NULL
another	NULL
,	NULL
Aiolos	NULL
localization	NULL
was	NULL
studied	NULL
in	NULL
intact	NULL
cells	NULL
using	NULL
indirect	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

IL-2-stimulated	NULL
or	NULL
-deprived	NULL
cells	NULL
were	NULL
attached	NULL
to	NULL
cover-slips	NULL
,	NULL
fixed	NULL
,	NULL
permeabilized	NULL
with	NULL
lysophosphatidylcholine	NULL
and	NULL
,	NULL
after	NULL
blocking	NULL
of	NULL
non-specific	NULL
binding	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
followed	NULL
by	NULL
fluorescein	NULL
isothi-ocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
secondary	NULL
antibody	NULL
.	NULL

Labelled	NULL
cells	NULL
were	NULL
observed	NULL
using	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

IL-2-stimulated	NULL
cells	NULL
show	NULL
strong	NULL
punctate	NULL
nuclear	NULL
stain-ing	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
cytoplasm	NULL
only	NULL
very	NULL
weak	NULL
staining	NULL
is	NULL
observed	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

After	NULL
3	NULL
h	NULL
of	NULL
lymphokine	NULL
deprivation	NULL
,	NULL
the	NULL
punctate	NULL
nuclear	NULL
staining	NULL
began	NULL
to	NULL
redistribute	NULL
gradu-ally	NULL
.	NULL

The	NULL
picture	NULL
after	NULL
6-9	NULL
h	NULL
of	NULL
IL-2	NULL
deprivation	NULL
shows	NULL
staining	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

Staining	NULL
distribution	NULL
at	NULL
12	NULL
h	NULL
of	NULL
deprivation	NULL
is	NULL
localized	NULL
progressively	NULL
throughout	NULL
the	NULL
cytoplasm	NULL
rather	NULL
than	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
at	NULL
24	NULL
h	NULL
after	NULL
withdrawal	NULL
the	NULL
staining	NULL
is	NULL
mainly	NULL
detected	NULL
in	NULL
the	NULL
cell	NULL
cytoplasm	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
IL-2	NULL
controls	NULL
cellular	NULL
Aiolos	NULL
distribution	NULL
.	NULL

Role	NULL
of	NULL
Aiolos	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
Bel-2	NULL
promoter	NULL
IL-2	NULL
deprivation	NULL
induces	NULL
apoptosis	NULL
and	NULL
Bcl-2	NULL
downregulation	NULL
in	NULL
TS1	NULL
@	NULL
f	NULL
cells	NULL
(	NULL
Gomez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998a	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
one	NULL
of	NULL
the	NULL
differences	NULL
between	NULL
IL-2-stimulated	NULL
and	NULL
IL-deprived	NULL
cells	NULL
is	NULL
Bcel-2	NULL
expression	NULL
,	NULL
and	NULL
that	NULL
Aiolos	NULL
is	NULL
mainly	NULL
detected	NULL
associated	NULL
with	NULL
Ras	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
Bel-2	NULL
transcription	NULL
may	NULL
be	NULL
activated	NULL
by	NULL
Aiolos	NULL
.	NULL

Bcl-2	NULL
expression	NULL
is	NULL
driven	NULL
by	NULL
two	NULL
promoters	NULL
,	NULL
P1	NULL
and	NULL
P2	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
was	NULL
therefore	NULL
performed	NULL
with	NULL
plasmids	NULL
in	NULL
which	NULL
luciferase	NULL
expression	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
P1	NULL
,	NULL
P2	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interaction	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
a-Aiolos	NULL
t	NULL
:	NULL
24	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Immunolocalization	NULL
of	NULL
Aiolos	NULL
.	NULL

IL-2-stimulated	NULL
(	NULL
5	NULL
ng/ml	NULL
!	NULL
)	NULL

cells	NULL
or	NULL
cells	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
different	NULL
periods	NULL
(	NULL
3-24	NULL
h	NULL
)	NULL
were	NULL
attached	NULL
to	NULL
a	NULL
glass	NULL
slide	NULL
,	NULL
fixed	NULL
,	NULL
permeabilized	NULL
with	NULL
lysophosphatidylcholine	NULL
and	NULL
stained	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
,	NULL
followed	NULL
by	NULL
FITC-conjugated	NULL
secondary	NULL
antibody	NULL
.	NULL

After	NULL
several	NULL
washing	NULL
steps	NULL
,	NULL
samples	NULL
were	NULL
mounted	NULL
in	NULL
the	NULL
surface	NULL
coating	NULL
Mowiol	NULL
with	NULL
anti-fading	NULL
agents	NULL
,	NULL
analysed	NULL
using	NULL
fluorescence	NULL
microscopy	NULL
and	NULL
photographed	NULL
using	NULL
a	NULL
phase-contrast	NULL
fluorescence	NULL
photomicroscope	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

or	NULL
P1+P2	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
plasmid	NULL
expressing	NULL
Aiolos	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
or	NULL
deprived	NULL
for	NULL
24	NULL
h	NULL
and	NULL
luciferase	NULL
expression	NULL
was	NULL
analysed	NULL
.	NULL

Transfection	NULL
of	NULL
Aiolos	NULL
with	NULL
an	NULL
irrelevant	NULL
promoter	NULL
(	NULL
A7mp55	NULL
IL-2R	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Co-transfection	NULL
experiments	NULL
in	NULL
cells	NULL
revealed	NULL
that	NULL
Aiolos	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
P1+P2	NULL
or	NULL
P1	NULL
Bcl-2	NULL
promoter	NULL
and	NULL
,	NULL
at	NULL
lower	NULL
levels	NULL
,	NULL
the	NULL
P2	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
,	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
only	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Cells	NULL
co-transfected	NULL
with	NULL
the	NULL
different	NULL
Bel-2	NULL
promoter	NULL
constructs	NULL
and	NULL
an	NULL
Aiolos	NULL
dimerization	NULL
domain	NULL
mutant	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
show	NULL
no	NULL
transactivation	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Aiolos	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
Bcl-2	NULL
promoter	NULL
construct	NULL
,	NULL
even	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

IL-2-stimulated	NULL
cells	NULL
transfected	NULL
only	NULL
with	NULL
Bel-2	NULL
promoter	NULL
reporter	NULL
constructs	NULL
show	NULL
lower	NULL
luciferase	NULL
activity	NULL
than	NULL
those	NULL
co-transfected	NULL
with	NULL
Aiolos	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Aiolos	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
Bel-2	NULL
promoter	NULL
construct	NULL
even	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

Aiolos	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
murine	NULL
A7mp55-IL-2R	NULL
promoter	NULL
,	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
enhanced	NULL
reporter	NULL
gene	NULL
activation	NULL
may	NULL
be	NULL
an	NULL
effect	NULL
of	NULL
Aiolos	NULL
on	NULL
the	NULL
Bel-2	NULL
promoter	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
we	NULL
detected	NULL
Aiolos-binding	NULL
sites	NULL
on	NULL
the	NULL
Bcl-2	NULL
promoter	NULL
identical	NULL
to	NULL
the	NULL
Aiolos	NULL
DNA-binding	NULL
sequence	NULL
described	NULL
by	NULL
Morgan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

To	NULL
prove	NULL
direct	NULL
control	NULL
of	NULL
Bel-2	NULL
expression	NULL
by	NULL
Aiolos	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
and	NULL
mutation	NULL
of	NULL
putative	NULL
Aiolos-binding	NULL
sites	NULL
within	NULL
the	NULL
Bel-2	NULL
promoter	NULL
were	NULL
performed	NULL
.	NULL

DNA-binding	NULL
activity	NULL
for	NULL
Aiolos	NULL
was	NULL
detected	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
Aiolos	NULL
DNA-binding	NULL
activity	NULL
was	NULL
detected	NULL
using	NULL
mutated	NULL
Aiolos-binding	NULL
sites	NULL
.	NULL

The	NULL
specific	NULL
DNA-Aiolos	NULL
interaction	NULL
was	NULL
confirmed	NULL
by	NULL
competition	NULL
with	NULL
unlabelled	NULL
oligonucleotide	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Cells	NULL
co-transfected	NULL
with	NULL
different	NULL
Bel-2	NULL
promoter	NULL
constructs	NULL
containing	NULL
mutated	NULL
Aiolos-binding	NULL
sites	NULL
and	NULL
Aiolos	NULL
expression	NULL
vector	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
show	NULL
no	NULL
transactivation	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
compared	NULL
with	NULL
cells	NULL
transfected	NULL
with	NULL
wild-type	NULL
Bcel-2	NULL
promoter	NULL
constructs	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
Aiolos	NULL
on	NULL
the	NULL
Bel-2	NULL
promoter	NULL
.	NULL

Aiolos	NULL
induces	NULL
Bel-2	NULL
expression	NULL
and	NULL
prevents	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
To	NULL
characterize	NULL
the	NULL
extent	NULL
to	NULL
which	NULL
Aiolos	NULL
activates	NULL
the	NULL
Bcl-2	NULL
promoter	NULL
,	NULL
transiently	NULL
transfected	NULL
cells	NULL
with	NULL
the	NULL
Aiolos	NULL
expression	NULL
vector	NULL
were	NULL
analysed	NULL
for	NULL
Bcl-2	NULL
expression	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

Cells	NULL
maintained	NULL
in	NULL
IL-2	NULL
or	NULL
IL-4	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
Bcel-2	NULL
expression	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

Upon	NULL
IL-2	NULL
stimulation	NULL
,	NULL
mock	NULL
transfectants	NULL
or	NULL
cells	NULL
transfected	NULL
with	NULL
Aiolos	NULL
show	NULL
Bcel-2	NULL
expression	NULL
levels	NULL
comparable	NULL
with	NULL
those	NULL
of	NULL
control	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

Mock	NULL
transfectants	NULL
maintained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
show	NULL
no	NULL
Bcl-2	NULL
expression	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
cells	NULL
are	NULL
transfected	NULL
with	NULL
Aiolos	NULL
,	NULL
weak	NULL
Bcl-2	NULL
expression	NULL
is	NULL
induced	NULL
without	NULL
IL-2	NULL
addition	NULL
.	NULL

Unaltered	NULL
Ras	NULL
expression	NULL
is	NULL
shown	NULL
3423	NULL
FRomero	NULL
et	NULL
al	NULL
.	NULL

A	NULL
+	NULL
Aiolos	NULL
_I—	NULL
-	NULL
Aiolos	NULL
51	NULL
-IL2	NULL
-IL2	NULL
-	NULL
}	NULL
-	NULL
RLU	NULL
x	NULL
103	NULL
a	NULL
los	NULL
_-	NULL
Aad	NULL
+	NULL
Aiolos	NULL
+1L-2	NULL
=	NULL
Aiolos	NULL
+	NULL
IL-2	NULL
o—I—c	NULL
RLU	NULL
x	NULL
103	NULL
ATmp55	NULL
IL-2R	NULL
RLU	NULL
x	NULL
103	NULL
IL-2	NULL
+o	NULL
+	NULL
-	NULL
AIOLOS	NULL
Fo	NULL
-	NULL
+	NULL
B	NULL
A	NULL
7	NULL
mp55	NULL
IL-2R	NULL
PROMOTER	NULL
TATAr	NULL
>	NULL
TATA|—	NULL
>	NULL
|	NULL
Bcl-2	NULL
PROMOTER	NULL
P1	NULL
P2	NULL
(	NULL
*	NULL
[	NULL
*	NULL
orr	NULL
AIOLOS	NULL
BINDING	NULL
SITE	NULL
:	NULL
T	NULL
G	NULL
G	NULL
G	NULL
A	NULL
A	NULL
Aiolos	NULL
1*	NULL
;	NULL
G	NULL
A	NULL
C	NULL
G	NULL
A	NULL
A	NULL
Aiolos	NULL
2*	NULL
:	NULL
A	NULL
T	NULL
G	NULL
G	NULL
A	NULL
A	NULL
Aiolos	NULL
3*	NULL
:	NULL
T	NULL
G	NULL
C	NULL
A	NULL
G	NULL
A	NULL
P1	NULL
LUCIFERASE	NULL
[	NULL
°	NULL
T	NULL
OJ	NULL
P2	NULL
LUCIFERASE	NULL
CITI	NULL
P1	NULL
P2	NULL
LUCIFERASE	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
Aiolos	NULL
on	NULL
transactivation	NULL
of	NULL
P1	NULL
,	NULL
P2	NULL
or	NULL
P1+P2	NULL
Bel-2	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
TS1GB	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
with	NULL
PI-Luc	NULL
,	NULL
P2-Luc	NULL
,	NULL
P1+P2-Luc	NULL
or	NULL
an	NULL
irrelevant	NULL
promoter	NULL
(	NULL
A7	NULL
murine	NULL
p55	NULL
IL-2R	NULL
promoter	NULL
)	NULL
,	NULL
with	NULL
or	NULL
without	NULL
Aiolos	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
IL-2	NULL
stimulated	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IL-2	NULL
deprived	NULL
for	NULL
24	NULL
h	NULL
,	NULL
collected	NULL
,	NULL
washed	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
transfection	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
-galactosidase	NULL
activity	NULL
.	NULL

Relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
were	NULL
normalized	NULL
to	NULL
protein	NULL
concentration	NULL
.	NULL

Standard	NULL
deviation	NULL
(	NULL
SD	NULL
)	NULL
is	NULL
shown	NULL
where	NULL
r	NULL
=	NULL
4	NULL
.	NULL

B	NULL
,	NULL
buffer	NULL
;	NULL
V	NULL
,	NULL
empty	NULL
vector	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
murine	NULL
A7mpS5IL-2R	NULL
and	NULL
Bel-2	NULL
promoters	NULL
showing	NULL
DNA-binding	NULL
sites	NULL
for	NULL
some	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
Aiolos	NULL
DNA-binding	NULL
sequence	NULL
and	NULL
the	NULL
mutated	NULL
Aiolos-binding	NULL
sites	NULL
(	NULL
Aiolos	NULL
1*	NULL
,	NULL
Aiolos	NULL
2*	NULL
and	NULL
Aiolos	NULL
3*	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
schematic	NULL
representation	NULL
of	NULL
P1	NULL
,	NULL
P2	NULL
and	NULL
P1+P2-luciferase	NULL
constructs	NULL
is	NULL
also	NULL
shown	NULL
.	NULL

under	NULL
all	NULL
transfection	NULL
conditions	NULL
as	NULL
an	NULL
internal	NULL
protein	NULL
loading	NULL
control	NULL
.	NULL

Expression	NULL
of	NULL
transiently	NULL
transfected	NULL
Aiolos	NULL
was	NULL
confirmed	NULL
by	NULL
direct	NULL
comparison	NULL
of	NULL
Aiolos	NULL
protein	NULL
levels	NULL
in	NULL
transfected	NULL
cells	NULL
and	NULL
in	NULL
mock-transfected	NULL
controls	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
Aiolos	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
Bcl-2	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
and	NULL
confirms	NULL
the	NULL
previous	NULL
result	NULL
of	NULL
Bel-2	NULL
promoter	NULL
activation	NULL
.	NULL

As	NULL
IL-2	NULL
deprivation	NULL
in	NULL
TS1	NULL
@	NULL
f®	NULL
cells	NULL
correlates	NULL
with	NULL
Bcl-2	NULL
downregulation	NULL
and	NULL
apoptosis	NULL
,	NULL
and	NULL
Aiolos	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
Bcel-2	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
Aiolos	NULL
may	NULL
prevent	NULL
apoptosis	NULL
.	NULL

Mock	NULL
transfectants	NULL
or	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Aiolos	NULL
expression	NULL
vector	NULL
were	NULL
selected	NULL
from	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
transfected	NULL
and	NULL
non-transfected	NULL
cells	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
Aiolos	NULL
and	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
24	NULL
h	NULL
show	NULL
a	NULL
strong	NULL
reduction	NULL
in	NULL
the	NULL
fraction	NULL
of	NULL
apoptotic	NULL
cells	NULL
compared	NULL
with	NULL
IL-2-deprived	NULL
mock-transfected	NULL
control	NULL
cells	NULL
(	NULL
Figure	NULL
9A	NULL
)	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
apoptotic	NULL
cells	NULL
remains	NULL
similar	NULL
in	NULL
all	NULL
transfected	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

Figure	NULL
9A	NULL
also	NULL
shows	NULL
the	NULL
percentage	NULL
of	NULL
apoptosis	NULL
in	NULL
non-transfected	NULL
cells	NULL
alone	NULL
or	NULL
cultured	NULL
in	NULL
IL-2	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
estimated	NULL
by	NULL
annexin	NULL
staining	NULL
(	NULL
Figure	NULL
9B	NULL
)	NULL
.	NULL

IL-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Aiolos	NULL
To	NULL
further	NULL
study	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interact	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
we	NULL
3424	NULL
analysed	NULL
whether	NULL
IL-2	NULL
could	NULL
induce	NULL
Aiolos	NULL
phosphorylation	NULL
,	NULL
which	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
its	NULL
dissociation	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
Aiolos	NULL
was	NULL
detected	NULL
in	NULL
Aiolos	NULL
immunoprecipitates	NULL
of	NULL
IL-2-stimulated	NULL
cell	NULL
cytoplasmic	NULL
lysates	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
cytoplasmic	NULL
tyrosine	NULL
phosphorylated	NULL
Aiolos	NULL
in	NULL
IL-2-deprived	NULL
immunoprecipitates	NULL
decreases	NULL
notably	NULL
after	NULL
12	NULL
h	NULL
of	NULL
starvation	NULL
,	NULL
and	NULL
is	NULL
almost	NULL
undetectable	NULL
after	NULL
24	NULL
h	NULL
of	NULL
deprivation	NULL
(	NULL
Figure	NULL
10A	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
Aiolos	NULL
immunoprecipitated	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
was	NULL
detected	NULL
by	NULL
reprobing	NULL
the	NULL
blot	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
,	NULL
showing	NULL
the	NULL
highest	NULL
levels	NULL
at	NULL
24	NULL
h	NULL
of	NULL
starvation	NULL
and	NULL
confirming	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Figure	NULL
2A	NULL
.	NULL

Tyrosine-phosphorylated	NULL
Aiolos	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
immunoprecipitates	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
IL-2-stimulated	NULL
cells	NULL
,	NULL
decreasing	NULL
strongly	NULL
with	NULL
the	NULL
starvation	NULL
period	NULL
(	NULL
Figure	NULL
10B	NULL
)	NULL
.	NULL

Nuclear	NULL
Aiolos	NULL
immunoprecipitated	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
was	NULL
detected	NULL
by	NULL
reprobing	NULL
the	NULL
blot	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
,	NULL
with	NULL
the	NULL
highest	NULL
Aiolos	NULL
levels	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

The	NULL
relative	NULL
amount	NULL
of	NULL
tyrosine-phosphorylated	NULL
Aiolos	NULL
in	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
normalized	NULL
to	NULL
total	NULL
Aiolos	NULL
protein	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
10C	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
IL-2	NULL
induces	NULL
phosphorylation	NULL
of	NULL
Aiolos	NULL
and	NULL
may	NULL
control	NULL
its	NULL
dissociation	NULL
from	NULL
Ras	NULL
.	NULL

Alternatively	NULL
,	NULL
IL-2	NULL
may	NULL
influence	NULL
the	NULL
state	NULL
of	NULL
Ras	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
its	NULL
dissociation	NULL
from	NULL
Aiolos	NULL
.	NULL

B	NULL
+Aiolos	NULL
«	NULL
IL-2	NULL
6	NULL
m	NULL
4	NULL
4	NULL
x	NULL
®	NULL
g	NULL
J	NULL
0	NULL
e	NULL
moo	NULL
L4	NULL
m	NULL
|_|	NULL
C	NULL
]	NULL
B	NULL
vo	NULL
PbO	NULL
P2	NULL
PLP	NULL
]	NULL
oB	NULL
vo	NULL
oP	NULL
oP	NULL
?	NULL

rie	NULL
?	NULL

Fig	NULL
.	NULL

7	NULL
.	NULL

DNA-binding	NULL
and	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
Aiolos	NULL
transcription	NULL
factor	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
proteins	NULL
from	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

cells	NULL
were	NULL
incubated	NULL
with	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
wild-type	NULL
(	NULL
TGGGAA	NULL
)	NULL
or	NULL
mutated	NULL
(	NULL
GACATG	NULL
)	NULL
Aiolos-binding	NULL
site	NULL
.	NULL

For	NULL
oligonucleotide	NULL
sequence	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
oligonucleotide	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
mutated	NULL
Aiolos-binding	NULL
site	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
Aiolos-binding	NULL
site	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
Aiolos-binding	NULL
site	NULL
competed	NULL
by	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
Aiolos-binding	NULL
site	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TS1	NULL
(	NULL
@	NULL
B	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
P1-Luc	NULL
,	NULL
P2-Luc	NULL
,	NULL
P1	NULL
+P2-Luc	NULL
orP1*-Luc	NULL
,	NULL
P2*-Luc	NULL
,	NULL
P1*+P2*-Lue	NULL
with	NULL
Aiolos	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
IL-2-deprived	NULL
for	NULL
24	NULL
h	NULL
,	NULL
collected	NULL
,	NULL
washed	NULL
and	NULL
analysed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
transfection	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
were	NULL
normalized	NULL
to	NULL
protein	NULL
concentration	NULL
.	NULL

B	NULL
,	NULL
buffer	NULL
;	NULL
V	NULL
,	NULL
empty	NULL
vector	NULL
.	NULL

P1*	NULL
,	NULL
P2*	NULL
or	NULL
P1*+P2*	NULL
represent	NULL
the	NULL
fragments	NULL
of	NULL
Bcl-2	NULL
promoter	NULL
with	NULL
mutated	NULL
Aiolos-binding	NULL
sites	NULL
.	NULL

For	NULL
oligonucleotide	NULL
sequence	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
and	NULL
Figure	NULL
6B	NULL
.	NULL

Discussion	NULL
Using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
approach	NULL
(	NULL
Fields	NULL
and	NULL
Song	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
Ras	NULL
wild-type	NULL
interacts	NULL
with	NULL
the	NULL
Aiolos	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
Ras	NULL
with	NULL
both	NULL
C-terminal	NULL
and	NULL
full-length	NULL
Aiolos	NULL
probably	NULL
requires	NULL
the	NULL
GDP	NULL
form	NULL
of	NULL
Ras	NULL
,	NULL
since	NULL
Ras	NULL
V12	NULL
or	NULL
N17	NULL
mutants	NULL
,	NULL
which	NULL
exist	NULL
in	NULL
GTP-bound	NULL
or	NULL
nucleotide	NULL
free	NULL
forms	NULL
,	NULL
respectively	NULL
(	NULL
Lai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
fail	NULL
to	NULL
interact	NULL
with	NULL
Aiolos	NULL
.	NULL

This	NULL
result	NULL
was	NULL
confirmed	NULL
by	NULL
in	NULL
vitro	NULL
binding	NULL
of	NULL
purified	NULL
fusion	NULL
proteins	NULL
containing	NULL
Ras	NULL
preincubated	NULL
with	NULL
GDP	NULL
or	NULL
GTP-yS	NULL
.	NULL

Aiolos	NULL
interacts	NULL
with	NULL
Ras-GDP	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
and	NULL
only	NULL
traces	NULL
of	NULL
Aiolos	NULL
are	NULL
detected	NULL
in	NULL
association	NULL
with	NULL
Ras-GDP	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
no	NULL
Aiolos	NULL
association	NULL
with	NULL
Ras-GTP	NULL
is	NULL
detected	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

Traces	NULL
of	NULL
Aiolos	NULL
were	NULL
associated	NULL
with	NULL
Ras-GTP	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
,	NULL
although	NULL
this	NULL
interaction	NULL
was	NULL
not	NULL
detected	NULL
using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
approach	NULL
.	NULL

Binding	NULL
probably	NULL
occurs	NULL
through	NULL
the	NULL
Ras	NULL
effector	NULL
domain	NULL
,	NULL
since	NULL
a	NULL
Ras	NULL
L35R37	NULL
effector	NULL
domain	NULL
mutant	NULL
does	NULL
not	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interaction	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
c	NULL
3	NULL
w	NULL
in	NULL
=	NULL
OE	NULL
zx	NULL
2	NULL
x-	NULL
2	NULL
$	NULL
o	NULL
f	NULL
$	NULL
G	NULL
jo	NULL
f	NULL
LJ	NULL
Uo	NULL
E	NULL
<	NULL
%	NULL
L	NULL
<	NULL
IL-2	NULL
+	NULL
+00	NULL
+0	NULL
IL-4	NULL
+	NULL
kDa	NULL
Bcel-2	NULL
«	NULL
amie	NULL
:	NULL
a	NULL
»	NULL
cap	NULL
26	NULL
Ras	NULL
«	NULL
tz	NULL
@	NULL
-	NULL
als	NULL
tam	NULL
Goo	NULL
21	NULL
Aiolos	NULL
P	NULL
smut	NULL
tut	NULL
Ament	NULL
56	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Transfection	NULL
of	NULL
Aiolos	NULL
induces	NULL
Bel-2	NULL
expression	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
or	NULL
without	NULL
Aiolos	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
and	NULL
stimulated	NULL
with	NULL
or	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
24	NULL
h.	NULL
After	NULL
transfection	NULL
,	NULL
protein	NULL
extracts	NULL
from	NULL
6X10°	NULL
cells	NULL
were	NULL
separated	NULL
in	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
probed	NULL
with	NULL
anti-Bcl-2	NULL
antibody	NULL
.	NULL

IL-2-	NULL
(	NULL
5	NULL
ng/ml	NULL
!	NULL
)	NULL

or	NULL
IL-4-stimulated	NULL
(	NULL
60	NULL
U/ml	NULL
!	NULL
)	NULL

cells	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
Bel-2	NULL
expression	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

Protein	NULL
bands	NULL
were	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

Hybridization	NULL
with	NULL
pan-Ras	NULL
is	NULL
shown	NULL
as	NULL
an	NULL
internal	NULL
protein	NULL
loading	NULL
control	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
transiently	NULL
transfected	NULL
Aiolos	NULL
was	NULL
confirmed	NULL
by	NULL
direct	NULL
comparison	NULL
of	NULL
Aiolos	NULL
protein	NULL
levels	NULL
in	NULL
transfected	NULL
and	NULL
mock	NULL
transfected	NULL
controls	NULL
.	NULL

Molecular	NULL
markers	NULL
are	NULL
shown	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

interact	NULL
with	NULL
Aiolos	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
.	NULL

Binding	NULL
of	NULL
Ras	NULL
wild-type	NULL
to	NULL
Aiolos	NULL
appears	NULL
to	NULL
be	NULL
Ras	NULL
protein	NULL
specific	NULL
,	NULL
since	NULL
other	NULL
Ras	NULL
superfamily	NULL
members	NULL
such	NULL
as	NULL
Racl	NULL
,	NULL
RacZ	NULL
,	NULL
RaplA	NULL
or	NULL
RalB	NULL
do	NULL
not	NULL
bind	NULL
Aiolos	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
method	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
using	NULL
the	NULL
two-hybrid	NULL
system	NULL
were	NULL
confirmed	NULL
by	NULL
in	NULL
vivo	NULL
experiments	NULL
.	NULL

In	NULL
co-immunoprecipitation	NULL
experiments	NULL
,	NULL
we	NULL
recovered	NULL
Aiolos	NULL
or	NULL
Ras	NULL
from	NULL
cytoplasmic	NULL
lysates	NULL
using	NULL
Ras-	NULL
or	NULL
Aiolos-specific	NULL
antibodies	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
Aiolos	NULL
is	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
IL-2-stimulated	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
mainly	NULL
found	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
IL-2-deprived	NULL
cells	NULL
.	NULL

This	NULL
suggests	NULL
a	NULL
distinct	NULL
cellular	NULL
distribution	NULL
of	NULL
Aiolos	NULL
depending	NULL
on	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

This	NULL
differential	NULL
Aiolos	NULL
distribution	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
of	NULL
total	NULL
extracts	NULL
and	NULL
by	NULL
immunofluorescence	NULL
of	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
which	NULL
showed	NULL
no	NULL
differences	NULL
in	NULL
total	NULL
protein	NULL
,	NULL
ruling	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
distribution	NULL
difference	NULL
is	NULL
due	NULL
to	NULL
variation	NULL
in	NULL
the	NULL
amounts	NULL
of	NULL
protein	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
IL-2	NULL
controls	NULL
the	NULL
cellular	NULL
distribution	NULL
of	NULL
Aiolos	NULL
.	NULL

Growth	NULL
factor	NULL
deprivation	NULL
induces	NULL
translocation	NULL
of	NULL
Aiolos	NULL
to	NULL
cytoplasm	NULL
,	NULL
coincident	NULL
with	NULL
induction	NULL
of	NULL
apoptosis	NULL
and	NULL
downregulation	NULL
of	NULL
Bel-2	NULL
expression	NULL
.	NULL

Whereas	NULL
Bcl-2	NULL
is	NULL
regulated	NULL
in	NULL
both	NULL
a	NULL
tissue-	NULL
and	NULL
time-specific	NULL
manner	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
regulatory	NULL
mechanism	NULL
governing	NULL
its	NULL
transcription	NULL
.	NULL

Two	NULL
promoter	NULL
regions	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
5	NULL
'	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
bei-2	NULL
gene	NULL
.	NULL

P1	NULL
is	NULL
a	NULL
TATA-less	NULL
,	NULL
GC-rich	NULL
region	NULL
containing	NULL
several	NULL
SP1	NULL
and	NULL
Rl	NULL
recognition	NULL
elements	NULL
(	NULL
Young	NULL
and	NULL
Korsmeyer	NULL
,	NULL
1993	NULL
;	NULL
Chen	NULL
and	NULL
Boxer	NULL
,	NULL
1995	NULL
;	NULL
Wilson	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

P2	NULL
,	NULL
located	NULL
~1.3	NULL
kb	NULL
downstream	NULL
of	NULL
3425	NULL
FRomero	NULL
et	NULL
al	NULL
.	NULL

A	NULL
+	NULL
IL-2	NULL
-	NULL
IL-2	NULL
2+1	NULL
%	NULL
21+4	NULL
%	NULL
Control	NULL
|	NULL
j	NULL
E	NULL
©	NULL
c	NULL
sh	NULL
bis	NULL
Tozd	NULL
a	NULL
rus	NULL
1024	NULL
7+3	NULL
%	NULL
30+5	NULL
%	NULL
Mock	NULL
|	NULL
$	NULL
G	NULL
c	NULL
c	NULL
s	NULL
a	NULL
fis	NULL
Toz	NULL
]	NULL
d	NULL
is	NULL
1024	NULL
4+3	NULL
%	NULL
10+2	NULL
%	NULL
Aiolos	NULL
|	NULL
i	NULL
3	NULL
c	NULL
c	NULL
«	NULL
I	NULL
=	NULL
a	NULL
*	NULL
'	NULL
dead	NULL
a	NULL
0C	NULL
i	NULL
~	NULL
ead	NULL
FLs	NULL
rus	NULL
B	NULL
+	NULL
IL-2	NULL
-	NULL
IL-2	NULL
4	NULL
%	NULL
27	NULL
%	NULL
3	NULL
``	NULL
1	NULL
Control	NULL
J	NULL
E	NULL
f	NULL
auc	NULL
r	NULL
lin	NULL
09d	NULL
*A	NULL
Tadd	NULL
anexth	NULL
exexth	NULL
5	NULL
%	NULL
38	NULL
%	NULL
#	NULL
ul	NULL
Mock	NULL
6	NULL
&	NULL
M	NULL
“	NULL
N	NULL
r	NULL
.	NULL

1	NULL
1008	NULL
7	NULL
%	NULL
14	NULL
%	NULL
]	NULL
&	NULL
.	NULL

{	NULL
dub	NULL
Aiolos	NULL
B	NULL
E	NULL
r	NULL
G	NULL
&	NULL
=	NULL
t	NULL
ql	NULL
``	NULL
'	NULL
_	NULL
'	NULL
_	NULL
i008	NULL
a	NULL
rt	NULL
``	NULL
anExXIN	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Cell-cycle	NULL
analysis	NULL
of	NULL
TS1	NULL
@	NULL
B	NULL
cells	NULL
transfected	NULL
with	NULL
Aiolos	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
or	NULL
without	NULL
Aiolos	NULL
and	NULL
pHook3	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
and	NULL
maintained	NULL
for	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
or	NULL
without	NULL
IL-2	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
selected	NULL
using	NULL
the	NULL
Capture-Tec	NULL
kit	NULL
from	NULL
Invitrogen	NULL
,	NULL
permeabilized	NULL
and	NULL
stained	NULL
with	NULL
PI	NULL
.	NULL

Samples	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
most	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
fluorescence	NULL
scale	NULL
represents	NULL
the	NULL
subG	NULL
;	NULL
region	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
apoptotic	NULL
cells	NULL
in	NULL
each	NULL
sample	NULL
are	NULL
superimposed	NULL
.	NULL

Non-transfected	NULL
cells	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
for	NULL
24	NULL
h	NULL
were	NULL
also	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Standard	NULL
deviation	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

After	NULL
selection	NULL
,	NULL
samples	NULL
were	NULL
diluted	NULL
in	NULL
ice-cold	NULL
binding	NULL
buffer	NULL
,	NULL
stained	NULL
with	NULL
annexin	NULL
and	NULL
PI	NULL
,	NULL
then	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
is	NULL
superimposed	NULL
.	NULL

P1	NULL
,	NULL
contains	NULL
a	NULL
CCAAT	NULL
box	NULL
,	NULL
an	NULL
octamer	NULL
motif	NULL
and	NULL
a	NULL
TATA	NULL
element	NULL
.	NULL

Although	NULL
transcriptional	NULL
regulators	NULL
of	NULL
Bel-2	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
Miyashita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Miyashita	NULL
and	NULL
Reed	NULL
,	NULL
1994	NULL
;	NULL
Taylor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Frampton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Hewitt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Heckman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
regulate	NULL
its	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
remains	NULL
uncharacterized	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
identify	NULL
Aiolos	NULL
as	NULL
the	NULL
first	NULL
transcription	NULL
factor	NULL
shown	NULL
to	NULL
regulate	NULL
the	NULL
Bcel-2	NULL
promoter	NULL
in	NULL
TS1o	NULL
@	NULL
fB	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
putative	NULL
Aiolos-binding	NULL
sites	NULL
in	NULL
the	NULL
Bel-2	NULL
promoter	NULL
identical	NULL
to	NULL
the	NULL
Aiolos	NULL
DNA-binding	NULL
sites	NULL
described	NULL
previously	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
Aiolos	NULL
is	NULL
indeed	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
Bcl-2	NULL
promoter	NULL
.	NULL

The	NULL
Aiolos-binding	NULL
sites	NULL
mentioned	NULL
above	NULL
are	NULL
probably	NULL
involved	NULL
in	NULL
this	NULL
effect	NULL
,	NULL
since	NULL
mutation	NULL
of	NULL
binding	NULL
sites	NULL
inhibits	NULL
transactivation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
other	NULL
adjacent	NULL
sequences	NULL
or	NULL
proteins	NULL
are	NULL
also	NULL
necessary	NULL
and	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
Aiolos	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
control	NULL
of	NULL
genes	NULL
other	NULL
than	NULL
Bcl-2	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
Bcl-2	NULL
transcription	NULL
from	NULL
the	NULL
proximal	NULL
P2	NULL
promoter	NULL
is	NULL
activated	NULL
in	NULL
neuronal	NULL
cells	NULL
by	NULL
the	NULL
Brn3a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
specifically	NULL
regulate	NULL
the	NULL
proximal	NULL
P2	NULL
promoter	NULL
region	NULL
,	NULL
the	NULL
predominant	NULL
promoter	NULL
in	NULL
neuronal	NULL
cells	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Aiolos	NULL
is	NULL
also	NULL
able	NULL
to	NULL
prevent	NULL
apoptosis	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
Bcl-2	NULL
expression	NULL
.	NULL

3426	NULL
Aiolos	NULL
is	NULL
first	NULL
detected	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
double	NULL
negative	NULL
(	NULL
CD4-CD8~	NULL
)	NULL
thymocyte	NULL
precursors	NULL
and	NULL
is	NULL
greatly	NULL
upregul-ated	NULL
as	NULL
these	NULL
progress	NULL
to	NULL
double	NULL
positive	NULL
(	NULL
CD4*CD8*	NULL
)	NULL
differentiation	NULL
stages	NULL
.	NULL

Aiolos	NULL
expression	NULL
decreases	NULL
in	NULL
splenic	NULL
T	NULL
cells	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

In	NULL
thymus	NULL
,	NULL
Bcel-2	NULL
is	NULL
expressed	NULL
in	NULL
double	NULL
negative	NULL
(	NULL
CD4~-CD8~	NULL
)	NULL
cells	NULL
and	NULL
in	NULL
a	NULL
few	NULL
double	NULL
positives	NULL
(	NULL
CD4*CD8*	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
nearly	NULL
all	NULL
single-positive	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Bel-2	NULL
is	NULL
expressed	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
(	NULL
Gratiot-Deans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Veis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Chao	NULL
and	NULL
Korsmeyer	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
Aiolos	NULL
and	NULL
Bel-2	NULL
expression	NULL
occur	NULL
in	NULL
parallel	NULL
throughout	NULL
the	NULL
lymphocyte	NULL
differentiation	NULL
stages	NULL
.	NULL

The	NULL
physiological	NULL
effects	NULL
of	NULL
lack	NULL
of	NULL
Aiolos	NULL
are	NULL
an	NULL
increase	NULL
in	NULL
B-cell	NULL
precursors	NULL
,	NULL
breakdown	NULL
in	NULL
B-cell	NULL
tolerance	NULL
and	NULL
development	NULL
of	NULL
B-cell	NULL
lymphomas	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
nonconventional	NULL
peritoneal	NULL
B	NULL
cells	NULL
and	NULL
recirculating	NULL
bone	NULL
marrow	NULL
B	NULL
cells	NULL
are	NULL
depleted	NULL
,	NULL
suggesting	NULL
that	NULL
Aiolos	NULL
plays	NULL
distinct	NULL
roles	NULL
in	NULL
signalling	NULL
cascades	NULL
that	NULL
control	NULL
differentiation	NULL
or	NULL
proliferation	NULL
of	NULL
nonconventional	NULL
versus	NULL
conventional	NULL
B	NULL
cells	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
IL-2	NULL
starvation	NULL
induces	NULL
Ras-A¥iolos	NULL
association	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
inhibition	NULL
of	NULL
Bel-2	NULL
expression	NULL
and	NULL
the	NULL
resulting	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

One	NULL
of	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
the	NULL
Ras-Aiolos	NULL
interaction	NULL
is	NULL
the	NULL
blockade	NULL
of	NULL
Aiolos	NULL
translocation	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
,	NULL
dephosphorylated	NULL
A	NULL
-IL-2	NULL
IL-2	NULL
12	NULL
24	NULL
kDa	NULL
IP	NULL
Aiolas	NULL
56	NULL
wB	NULL
PTyr	NULL
|=	NULL
+	NULL
I	NULL
IP	NULL
Aiolos	NULL
«	NULL
itm	NULL
.	NULL

Speer	NULL
56	NULL
wB	NULL
Aiolos	NULL
1	NULL
IP	NULL
Ajolos	NULL
I	NULL
~-	NULL
``	NULL
.	NULL

a*	NULL
wB	NULL
PTyr	NULL
k	NULL
``	NULL
>	NULL
>	NULL
...	NULL
s	NULL
cams	NULL
``	NULL
IP	NULL
Aiolos	NULL
s	NULL
a	NULL
56	NULL
wB	NULL
Aiolos	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interaction	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
C	NULL
150	NULL
Cytoplasmic	NULL
Integrated	NULL
Density	NULL
(	NULL
Arbitrary	NULL
Units	NULL
)	NULL
200	NULL
Nuclear	NULL
Integrated	NULL
Density	NULL
(	NULL
Arbitrary	NULL
Units	NULL
)	NULL
IL-2-deprivation	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

IL-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Aiolos	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cytoplasmic	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
1X10	NULL
``	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Aiolos	NULL
,	NULL
washed	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
probed	NULL
with	NULL
anti-PTyr	NULL
antibody	NULL
.	NULL

To	NULL
detect	NULL
cytoplasmic	NULL
Aiolos	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
probed	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
.	NULL

Protein	NULL
bands	NULL
were	NULL
detected	NULL
using	NULL
the	NULL
ECL	NULL
system	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
proteins	NULL
isolated	NULL
from	NULL
IL-2-stimulated	NULL
(	NULL
5	NULL
ng/ml	NULL
!	NULL
)	NULL

or	NULL
IL-2-deprived	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Aiolos	NULL
,	NULL
washed	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
probed	NULL
with	NULL
anti-PTyr	NULL
antibody	NULL
.	NULL

To	NULL
detect	NULL
nuclear	NULL
Aiolos	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
probed	NULL
with	NULL
anti-Aiolos	NULL
antibody	NULL
.	NULL

Protein	NULL
bands	NULL
were	NULL
detected	NULL
using	NULL
ECL	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Densitometric	NULL
analysis	NULL
of	NULL
phosphorylated	NULL
Aiolos	NULL
(	NULL
dotted	NULL
bar	NULL
)	NULL
versus	NULL
total	NULL
Aiolos	NULL
protein	NULL
(	NULL
grey	NULL
bar	NULL
)	NULL
of	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

Blots	NULL
from	NULL
Figure	NULL
10A	NULL
and	NULL
B	NULL
were	NULL
measured	NULL
by	NULL
densitometry	NULL
using	NULL
the	NULL
NIH	NULL
program	NULL
.	NULL

After	NULL
background	NULL
subtraction	NULL
,	NULL
tyrosine-phosphorylated	NULL
Aiolos	NULL
was	NULL
normalized	NULL
to	NULL
total	NULL
Aiolos	NULL
protein	NULL
.	NULL

Aiolos	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
Ras	NULL
,	NULL
there	NULL
is	NULL
no	NULL
Bcl-2	NULL
expression	NULL
,	NULL
and	NULL
apoptosis	NULL
is	NULL
induced	NULL
as	NULL
a	NULL
consequence	NULL
.	NULL

The	NULL
suppression	NULL
of	NULL
Aiolos	NULL
nuclear	NULL
translocation	NULL
is	NULL
blocked	NULL
by	NULL
IL-2	NULL
addition	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Aiolos	NULL
and	NULL
probably	NULL
dissociation	NULL
from	NULL
Ras	NULL
.	NULL

Alternatively	NULL
,	NULL
IL-2	NULL
may	NULL
influence	NULL
the	NULL
state	NULL
of	NULL
Ras	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
its	NULL
dissociation	NULL
from	NULL
Aiolos	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
results	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
IL-2	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
Ras-Aiolos	NULL
interaction	NULL
.	NULL

IL-2-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Aiolos	NULL
probably	NULL
diminishes	NULL
the	NULL
affinity	NULL
of	NULL
Aiolos	NULL
for	NULL
Ras	NULL
,	NULL
inducing	NULL
its	NULL
dissociation	NULL
and	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
in	NULL
IL-2-starved	NULL
cells	NULL
,	NULL
Ras	NULL
will	NULL
be	NULL
in	NULL
a	NULL
so-called	NULL
inactive	NULL
GDP-bound	NULL
state	NULL
and	NULL
will	NULL
therefore	NULL
be	NULL
able	NULL
to	NULL
bind	NULL
Aiolos	NULL
,	NULL
working	NULL
as	NULL
a	NULL
cytoplasmic	NULL
trap	NULL
for	NULL
Aiolos	NULL
.	NULL

We	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
phosphorylated	NULL
Aiolos	NULL
increases	NULL
its	NULL
affinity	NULL
for	NULL
other	NULL
partners	NULL
that	NULL
would	NULL
allow	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
that	NULL
Ras	NULL
might	NULL
also	NULL
increase	NULL
its	NULL
affinity	NULL
for	NULL
other	NULL
effectors	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
the	NULL
pool	NULL
of	NULL
transcription	NULL
factor	NULL
Aiolos	NULL
involved	NULL
in	NULL
Bel-2	NULL
expression	NULL
control	NULL
is	NULL
in	NULL
a	NULL
phosphorylated	NULL
or	NULL
unphosphorylated	NULL
form	NULL
.	NULL

Our	NULL
data	NULL
demonstrate	NULL
a	NULL
specific	NULL
interaction	NULL
between	NULL
Aiolos	NULL
and	NULL
Ras	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
,	NULL
and	NULL
provide	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
disruption	NULL
of	NULL
Bel-2	NULL
expression	NULL
due	NULL
to	NULL
the	NULL
cytoplasmic	NULL
localization	NULL
of	NULL
the	NULL
Aiolos	NULL
transcription	NULL
factor	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
is	NULL
the	NULL
first	NULL
report	NULL
describing	NULL
the	NULL
role	NULL
of	NULL
Aiolos	NULL
in	NULL
Bel-2	NULL
promoter	NULL
activation	NULL
.	NULL

We	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
Ras-Aiolos	NULL
interaction	NULL
could	NULL
also	NULL
be	NULL
regulated	NULL
by	NULL
other	NULL
proteins	NULL
.	NULL

The	NULL
finding	NULL
reported	NULL
here	NULL
suggests	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
Ras	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
as	NULL
a	NULL
blocker	NULL
of	NULL
Bcel-2	NULL
expression	NULL
through	NULL
the	NULL
cytoplasmic	NULL
sequestering	NULL
of	NULL
unphosphorylated	NULL
Aiolos	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cells	NULL
and	NULL
cultures	NULL
TSlaB	NULL
is	NULL
a	NULL
murine	NULL
T-cell	NULL
line	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
-	NULL
and	NULL
B-chains	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
(	NULL
Pitton	NULL
etal	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
and	NULL
can	NULL
be	NULL
maintained	NULL
independently	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
or	NULL
IL-9	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Gibco-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
0.55	NULL
mM	NULL
arginine	NULL
,	NULL
0.24	NULL
mM	NULL
asparagine	NULL
,	NULL
50	NULL
uM	NULL
2-ME	NULL
and	NULL
5	NULL
ng/ml	NULL
of	NULL
recombinant	NULL
IL-2	NULL
(	NULL
IL-2	NULL
)	NULL
or	NULL
60	NULL
U/	NULL
ml	NULL
of	NULL
IL-4	NULL
.	NULL

Lymphokines	NULL
,	NULL
antibodies	NULL
,	NULL
reagents	NULL
,	NULL
plasmids	NULL
and	NULL
probes	NULL
Human	NULL
IL-2	NULL
was	NULL
provided	NULL
by	NULL
Roussel	NULL
Uclaf	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Murine	NULL
rIL-4	NULL
or	NULL
supernatant	NULL
of	NULL
a	NULL
HeLa	NULL
subline	NULL
transfected	NULL
with	NULL
pKCRIL-4.neo	NULL
was	NULL
used	NULL
as	NULL
source	NULL
of	NULL
murine	NULL
IL-4	NULL
.	NULL

Mouse	NULL
pan-Ras	NULL
was	NULL
from	NULL
Oncogene	NULL
Science	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
anti-mouse	NULL
Bcl-2	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
was	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
anti-mouse	NULL
Aiolos	NULL
polyclonal	NULL
antibody	NULL
was	NULL
generated	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

Peroxidase-conjugated	NULL
(	NULL
PO	NULL
)	NULL
goat	NULL
anti-rabbit	NULL
or	NULL
anti-mouse	NULL
Ig	NULL
antibody	NULL
was	NULL
from	NULL
Dako	NULL
(	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

ECL	NULL
or	NULL
ECL	NULL
Plus	NULL
and	NULL
y-°°P	NULL
reagents	NULL
were	NULL
from	NULL
Amersham	NULL
(	NULL
Amersham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

NP-40	NULL
was	NULL
from	NULL
Boehringer-Mannheim	NULL
(	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Propidium	NULL
iodide	NULL
(	NULL
PD	NULL
)	NULL
,	NULL
Mowiol	NULL
,	NULL
anti-histone	NULL
antibodies	NULL
and	NULL
glutathione-agarose	NULL
beads	NULL
were	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
DEAE-dextran	NULL
was	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Capture-Tec	NULL
pHook-3	NULL
kit	NULL
was	NULL
from	NULL
Invitrogen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
annexin	NULL
kit	NULL
was	NULL
from	NULL
Immunotech	NULL
(	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
and	NULL
the	NULL
QuikChange	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
from	NULL
Stratagene	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

P1	NULL
,	NULL
P2	NULL
or	NULL
P1+2	NULL
Bcl-2	NULL
promoter	NULL
region	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
and	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
N.Israel	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
B-actin	NULL
probe	NULL
was	NULL
a	NULL
Clal-BamHI	NULL
600	NULL
bp	NULL
fragment	NULL
.	NULL

The	NULL
Aiolos	NULL
probe	NULL
was	NULL
a	NULL
330	NULL
bp	NULL
fragment	NULL
from	NULL
the	NULL
last	NULL
exon	NULL
of	NULL
Aiolos	NULL
,	NULL
which	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Ikaros	NULL
.	NULL

Probes	NULL
were	NULL
labelled	NULL
3427	NULL
FRomero	NULL
et	NULL
al	NULL
.	NULL

with	NULL
[	NULL
P°PJATP	NULL
.	NULL

The	NULL
pS5-Luc	NULL
IL-2R	NULL
promoter	NULL
was	NULL
provided	NULL
by	NULL
Dr	NULL
M.Nabholz	NULL
(	NULL
Lausanne	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Anti-IL-2	NULL
antibody	NULL
was	NULL
provided	NULL
by	NULL
Dr	NULL
A.Dautriche	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
,	NULL
pGEX-Vav-SH2	NULL
was	NULL
given	NULL
by	NULL
Dr	NULL
$	NULL
.Fischer	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
and	NULL
the	NULL
Ras	NULL
mutant	NULL
L35R37	NULL
by	NULL
Dr	NULL
A.Vojtek	NULL
(	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
.	NULL

The	NULL
RapA	NULL
construct	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr	NULL
J.de	NULL
Gunzburg	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

cDNA	NULL
library	NULL
and	NULL
the	NULL
two-hybrid	NULL
screen	NULL
Two	NULL
cDNA	NULL
libraries	NULL
from	NULL
IL-2-stimulated	NULL
or	NULL
16	NULL
h	NULL
IL-2-deprived	NULL
TS1a	NULL
$	NULL
B	NULL
cells	NULL
from	NULL
polyadenylated	NULL
RNA	NULL
were	NULL
constructed	NULL
in	NULL
fusion	NULL
with	NULL
Gal4	NULL
activation	NULL
domain	NULL
(	NULL
AD	NULL
)	NULL
in	NULL
pGAD10	NULL
(	NULL
Bartel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Wild-type	NULL
Ras	NULL
cloned	NULL
into	NULL
the	NULL
pLex10	NULL
vector	NULL
was	NULL
used	NULL
as	NULL
bait	NULL
to	NULL
screen	NULL
both	NULL
cDNA	NULL
libraries	NULL
in	NULL
the	NULL
Saccharomyces	NULL
cerevisiae	NULL
LAO	NULL
strain	NULL
(	NULL
MATa	NULL
trp	NULL
!	NULL

leu	NULL
?	NULL

his3	NULL
LYSZ	NULL
:	NULL
=lexA-His3	NULL
,	NULL
URA3	NULL
:	NULL
:	NULL
lexA-lacZ	NULL
)	NULL
using	NULL
standard	NULL
procedures	NULL
(	NULL
Bartel	NULL
and	NULL
Field	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
Sequencing	NULL
of	NULL
PCR	NULL
fragments	NULL
and	NULL
cDNA	NULL
inserts	NULL
from	NULL
positive	NULL
clones	NULL
of	NULL
the	NULL
two-hybrid	NULL
screening	NULL
was	NULL
performed	NULL
on	NULL
both	NULL
strands	NULL
with	NULL
an	NULL
automatic	NULL
sequencer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
model	NULL
373A	NULL
)	NULL
.	NULL

Sequences	NULL
were	NULL
compared	NULL
using	NULL
the	NULL
FASTA	NULL
program	NULL
.	NULL

Cloning	NULL
of	NULL
Aiolos	NULL
According	NULL
to	NULL
the	NULL
published	NULL
sequence	NULL
,	NULL
Aiolos	NULL
was	NULL
cloned	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
5'-ATGGAAGATATACAACCG	NULL
and	NULL
3'-GTGTCT-CGGTACAACTTC	NULL
.	NULL

Amplified	NULL
DNA	NULL
of	NULL
the	NULL
correct	NULL
size	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
and	NULL
was	NULL
cloned	NULL
in	NULL
the	NULL
pcDNA	NULL
expression	NULL
vector	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
Cells	NULL
(	NULL
1X10	NULL
'	NULL
)	NULL
were	NULL
IL-2	NULL
stimulated	NULL
or	NULL
IL-2	NULL
deprived	NULL
,	NULL
and	NULL
lysed	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
and	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
appropriate	NULL
antibody	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
was	NULL
added	NULL
for	NULL
1h	NULL
at	NULL
4°C	NULL
and	NULL
,	NULL
after	NULL
washing	NULL
,	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
(	NULL
1X10°	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
and	NULL
protein	NULL
extracts	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
non-fat	NULL
milk	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
;	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaC	NULL
)	NULL
]	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
primary	NULL
antibody	NULL
in	NULL
TBS/0.5	NULL
%	NULL
non-fat	NULL
dry	NULL
milk	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
with	NULL
0.05	NULL
%	NULL
Tween-20	NULL
in	NULL
TBS	NULL
and	NULL
incubated	NULL
with	NULL
PO-conjugated	NULL
second	NULL
antibody	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
proteins	NULL
were	NULL
developed	NULL
using	NULL
the	NULL
ECL	NULL
or	NULL
ECL	NULL
Plus	NULL
system	NULL
.	NULL

When	NULL
stripping	NULL
was	NULL
required	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
62.5	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
pH	NULL
6.8	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
and	NULL
0.1	NULL
M	NULL
2-ME	NULL
for	NULL
1	NULL
h	NULL
at	NULL
65°C	NULL
and	NULL
washed	NULL
extensively	NULL
with	NULL
TBS	NULL
buffer	NULL
before	NULL
reblocking	NULL
and	NULL
probing	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
IL-2-stimulated	NULL
or	NULL
IL-2-deprived	NULL
cells	NULL
(	NULL
2	NULL
X10	NULL
``	NULL
)	NULL
were	NULL
resuspended	NULL
for	NULL
2	NULL
min	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
pH	NULL
8	NULL
,	NULL
0.5	NULL
M	NULL
sucrose	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
and	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
centrifuged	NULL
(	NULL
4500	NULL
g	NULL
,	NULL
3	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
buffer	NULL
B	NULL
(	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
pH	NULL
8	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
spermidine	NULL
and	NULL
0.15	NULL
mM	NULL
spermine	NULL
)	NULL
and	NULL
centrifuged	NULL
(	NULL
4500	NULL
g	NULL
,	NULL
3	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
60	NULL
pul	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
350	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
pH	NULL
8	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
spermidine	NULL
and	NULL
0.15	NULL
mM	NULL
spermine	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
buffers	NULL
were	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
.	NULL

End-labelled	NULL
oligonucleotides	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
were	NULL
incubated	NULL
(	NULL
room	NULL
temperature	NULL
,	NULL
15	NULL
min	NULL
)	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.25	NULL
ng	NULL
of	NULL
single-stranded	NULL
(	NULL
ss	NULL
)	NULL
DNA	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
0.01	NULL
%	NULL
NP-40	NULL
,	NULL
0.1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
and	NULL
4	NULL
%	NULL
Ficoll	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
probe	NULL
on	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
X	NULL
TBE	NULL
(	NULL
90	NULL
mM	NULL
Tris	NULL
,	NULL
90	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
1.5	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
after	NULL
which	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

A	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
oligonucleotide	NULL
was	NULL
used	NULL
to	NULL
compete	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
radiolabelled	NULL
probe	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
single	NULL
Aiolos-binding	NULL
site	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
5'-TCAGCTTTIGGG-AATACCCTGTCA	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
single	NULL
mutated	NULL
Aiolos	NULL
binding	NULL
site	NULL
was	NULL
:	NULL
Preparation	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
Aiolos	NULL
was	NULL
inserted	NULL
in	NULL
the	NULL
pGEX	NULL
4T1	NULL
vector	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
GST	NULL
fusion	NULL
proteins	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
mM	NULL
isopropyl-B-p-thiogalactopyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
and	NULL
the	NULL
fusion	NULL
pro	NULL
3428	NULL
teins	NULL
were	NULL
isolated	NULL
from	NULL
bacterial	NULL
lysates	NULL
by	NULL
affinity	NULL
chromatography	NULL
with	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

For	NULL
purity	NULL
control	NULL
,	NULL
proteins	NULL
were	NULL
eluted	NULL
from	NULL
agarose	NULL
beads	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
separated	NULL
in	NULL
10	NULL
%	NULL
PAGE	NULL
and	NULL
stained	NULL
with	NULL
Coomassie	NULL
Blue	NULL
.	NULL

For	NULL
the	NULL
GST-Ras	NULL
expression	NULL
plasmid	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
induction	NULL
,	NULL
resuspended	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
supplemented	NULL
with	NULL
20	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mg/ml	NULL
lysozyme	NULL
,	NULL
10	NULL
mM	NULL
GDP	NULL
or	NULL
GTP-yS	NULL
and	NULL
protease	NULL
inhibitors	NULL
.	NULL

Following	NULL
10	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
suspension	NULL
was	NULL
supplemented	NULL
with	NULL
25	NULL
mM	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
5	NULL
mM	NULL
EDTA	NULL
.	NULL

Cells	NULL
were	NULL
broken	NULL
by	NULL
sonication	NULL
,	NULL
the	NULL
supernatant	NULL
removed	NULL
after	NULL
centrifugation	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
with	NULL
a	NULL
suspension	NULL
of	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

The	NULL
agarose	NULL
was	NULL
washed	NULL
with	NULL
washing	NULL
buffer	NULL
(	NULL
Tris	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
GDP	NULL
or	NULL
GTP-yS	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
and	NULL
protease	NULL
inhibitors	NULL
)	NULL
.	NULL

RNA	NULL
isolation	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
following	NULL
the	NULL
method	NULL
of	NULL
Maniatis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
RNA	NULL
samples	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
in	NULL
the	NULL
presenceof	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
.	NULL

After	NULL
hybridization	NULL
with	NULL
the	NULL
probe	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
washed	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
at	NULL
-70°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
encoding	NULL
B-actin	NULL
.	NULL

Luciferase	NULL
assay	NULL
Cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
or	NULL
without	NULL
the	NULL
peDNA	NULL
Aiolos	NULL
plasmid	NULL
plus	NULL
Pl-Luc	NULL
,	NULL
P2-Lue	NULL
or	NULL
P1+P2-Luc	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
Aiolos	NULL
plus	NULL
P1*-Luc	NULL
,	NULL
P2*-Luc	NULL
or	NULL
P1*+P2*	NULL
Luc	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
peDNA	NULL
Aiolos	NULL
and	NULL
A7mpS5IL-2R-Luc	NULL
or	NULL
empty	NULL
vector	NULL
pcDNA	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
5	NULL
ng/ml	NULL
of	NULL
rIL-2	NULL
for	NULL
24	NULL
h	NULL
,	NULL
then	NULL
washed	NULL
in	NULL
cold	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
Luc	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-phosphate	NULL
pH	NULL
7.8	NULL
,	NULL
8	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
15	NULL
%	NULL
glycerol	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Extracts	NULL
were	NULL
diluted	NULL
in	NULL
Luc	NULL
buffer	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
prepared	NULL
with	NULL
91	NULL
ul	NULL
of	NULL
25	NULL
mM	NULL
luciferin	NULL
,	NULL
330	NULL
pul	NULL
of	NULL
20	NULL
mM	NULL
ATP	NULL
and	NULL
4606	NULL
ul	NULL
of	NULL
Luc	NULL
buffer	NULL
.	NULL

Luciferase	NULL
activity	NULL
in	NULL
protein	NULL
extracts	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
Berthold	NULL
LB9501	NULL
luminometer	NULL
.	NULL

Transient	NULL
transfection	NULL
TSlaB	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
.	NULL

Cells	NULL
10°	NULL
)	NULL
in	NULL
exponential	NULL
growth	NULL
were	NULL
washed	NULL
with	NULL
TS	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
0.7	NULL
mM	NULL
CaC	NULL
)	NULL
;	NULL
,	NULL
0.5	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
and	NULL
0.6	NULL
mM	NULL
Na	NULL
;	NULL
HPO	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
plasmid	NULL
pHook-3	NULL
and	NULL
pcDNA	NULL
Aiolos	NULL
or	NULL
an	NULL
irrelevant	NULL
plasmid	NULL
.	NULL

pHook-3	NULL
vector	NULL
expresses	NULL
a	NULL
hapten-specific	NULL
single	NULL
chain	NULL
antibody	NULL
(	NULL
sFv	NULL
)	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
transfected	NULL
cells	NULL
.	NULL

A	NULL
total	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
,	NULL
375	NULL
ul	NULL
of	NULL
TS	NULL
buffer	NULL
and	NULL
375	NULL
pul	NULL
of	NULL
freshly	NULL
prepared	NULL
DEAE-dextran	NULL
(	NULL
1	NULL
mg/m	NULL
!	NULL
)	NULL

in	NULL
TS	NULL
buffer	NULL
were	NULL
mixed	NULL
successively	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
(	NULL
20	NULL
min	NULL
,	NULL
room	NULL
temperature	NULL
)	NULL
and	NULL
13	NULL
ml	NULL
of	NULL
RPMI-1640/5	NULL
%	NULL
FCS	NULL
were	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
(	NULL
1	NULL
h	NULL
,	NULL
37°C	NULL
)	NULL
,	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
12	NULL
ml	NULL
of	NULL
RPMI-1640/5	NULL
%	NULL
FCS	NULL
alone	NULL
or	NULL
supplemented	NULL
with	NULL
5	NULL
ng/ml	NULL
of	NULL
rIL-2	NULL
.	NULL

Cells	NULL
expressing	NULL
the	NULL
sFV	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
culture	NULL
by	NULL
binding	NULL
to	NULL
hapten-coated	NULL
(	NULL
pHOX	NULL
)	NULL
magnetic	NULL
beads	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
selected	NULL
and	NULL
analysed	NULL
.	NULL

Cell-cycle	NULL
analysis	NULL
A	NULL
total	NULL
of	NULL
2.5X10°	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
,	NULL
permeabilized	NULL
with	NULL
0.1	NULL
%	NULL
NP-40	NULL
and	NULL
stained	NULL
with	NULL
50	NULL
ug/ml	NULL
PI	NULL
immediately	NULL
before	NULL
analysis	NULL
.	NULL

Samples	NULL
were	NULL
analysed	NULL
using	NULL
an	NULL
EpicsXL	NULL
flow	NULL
cytometer	NULL
(	NULL
Coulter	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
measured	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
subG	NULL
;	NULL
region	NULL
of	NULL
the	NULL
fluorescence	NULL
scale	NULL
having	NULL
a	NULL
hypodiploid	NULL
DNA	NULL
content	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
were	NULL
diluted	NULL
in	NULL
ice-cold	NULL
binding	NULL
buffer	NULL
,	NULL
stained	NULL
with	NULL
annexin	NULL
and	NULL
PI	NULL
,	NULL
then	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
IL-2-stimulated	NULL
cells	NULL
,	NULL
or	NULL
cells	NULL
IL2	NULL
deprived	NULL
for	NULL
different	NULL
periods	NULL
were	NULL
harvested	NULL
and	NULL
centrifuged	NULL
in	NULL
a	NULL
cytospin	NULL
(	NULL
Heraeus	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
600	NULL
g	NULL
on	NULL
glass	NULL
slides	NULL
.	NULL

Cells	NULL
were	NULL
methanol	NULL
fixed	NULL
for	NULL
2	NULL
min	NULL
at	NULL
-20°C	NULL
and	NULL
permeabilized	NULL
with	NULL
50	NULL
ug/ml	NULL
of	NULL
lysophosphatidylcholine	NULL
in	NULL
PBS	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
1	NULL
%	NULL
PBS/BSA	NULL
.	NULL

Polyclonal	NULL
anti-Aiolos	NULL
antibody	NULL
diluted	NULL
in	NULL
PBS/BSA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
slides	NULL
under	NULL
a	NULL
cover-slip	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
humidified	NULL
chamber	NULL
(	NULL
1	NULL
h	NULL
,	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
once	NULL
with	NULL
PBS	NULL
and	NULL
twice	NULL
with	NULL
PBS/BSA	NULL
,	NULL
secondary	NULL
fluores-ceinated	NULL
antibody	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
in	NULL
a	NULL
humidified	NULL
chamber	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
washing	NULL
three	NULL
times	NULL
with	NULL
PBS/BSA	NULL
and	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
slides	NULL
were	NULL
mounted	NULL
in	NULL
Mowiol	NULL
with	NULL
antifading	NULL
agent	NULL
.	NULL

Samples	NULL
were	NULL
analysed	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
and	NULL
photographed	NULL
using	NULL
a	NULL
Nikon	NULL
Optiphot2	NULL
phase-contrast	NULL
fluorescence	NULL
photomicroscope	NULL
.	NULL

Peptide	NULL
synthesis	NULL
and	NULL
antibody	NULL
production	NULL
A	NULL
specific	NULL
peptide	NULL
of	NULL
the	NULL
Aiolos	NULL
amino	NULL
acid	NULL
sequence	NULL
368-384	NULL
was	NULL
synthesized	NULL
on	NULL
an	NULL
automated	NULL
multiple	NULL
peptide	NULL
synthesizer	NULL
(	NULL
AMS422	NULL
,	NULL
Abimed	NULL
,	NULL
Langefeld	NULL
,	NULL
Germany	NULL
)	NULL
using	NULL
the	NULL
solid	NULL
phase	NULL
procedure	NULL
and	NULL
standard	NULL
Fmoc	NULL
chemistry	NULL
.	NULL

Purity	NULL
and	NULL
peptide	NULL
composition	NULL
were	NULL
confirmed	NULL
in	NULL
reverse-phase	NULL
HPLC	NULL
and	NULL
by	NULL
amino	NULL
acid	NULL
analysis	NULL
in	NULL
a	NULL
Beckman	NULL
6300	NULL
amino	NULL
acid	NULL
analyser	NULL
.	NULL

The	NULL
peptide	NULL
,	NULL
glutaraldehyde-coupled	NULL
to	NULL
KLH	NULL
via	NULL
N-terminal	NULL
lysine	NULL
,	NULL
was	NULL
injected	NULL
into	NULL
outbred	NULL
New	NULL
Zealand	NULL
rabbits	NULL
.	NULL

Sera	NULL
were	NULL
collected	NULL
7-10	NULL
days	NULL
after	NULL
the	NULL
last	NULL
injection	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
Site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
QuikChange	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
for	NULL
mutation	NULL
were	NULL
:	NULL
Aiolos	NULL
1*	NULL
:	NULL
5-GAAGCAGAAGTCGACGAATCGATCTGGAAATCC	NULL
;	NULL
Aiolos	NULL
2*	NULL
:	NULL
5	NULL
``	NULL
-CTCCTGATTCATATGGAAGTTTITTCAAATCAGCTA	NULL
;	NULL
Aiolos	NULL
3*	NULL
:	NULL
5-TTTTCCTCTGCAGAGGATG	NULL
.	NULL

The	NULL
putative	NULL
Aiolos-binding	NULL
site	NULL
is	NULL
underlined	NULL
.	NULL

Point	NULL
mutations	NULL
are	NULL
shown	NULL
in	NULL
bold	NULL
.	NULL

Acknowledgements	NULL
We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Drs	NULL
N.Israel	NULL
,	NULL
M.Nabholz	NULL
,	NULL
A.Dautriche	NULL
,	NULL
S.Fischer	NULL
,	NULL
A.Vojtek	NULL
and	NULL
J.de	NULL
Gunzburg	NULL
for	NULL
gifts	NULL
of	NULL
reagents	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
Ms	NULL
IPoveda	NULL
for	NULL
help	NULL
with	NULL
photographic	NULL
work	NULL
and	NULL
C.Mark	NULL
for	NULL
editorial	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
also	NULL
partially	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
ARC	NULL
and	NULL
the	NULL
EC	NULL
(	NULL
BIO4-CT96-1110	NULL
)	NULL
.	NULL

The	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Oncology	NULL
was	NULL
founded	NULL
and	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
Spanish	NULL
Research	NULL
Council	NULL
(	NULL
CSIC	NULL
)	NULL
and	NULL
Pharmacia	NULL
&	NULL
Upjohn	NULL
.	NULL

References	NULL
Bartel	NULL
,	NULL
PL	NULL
.	NULL

and	NULL
Field	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
Yeast	NULL
Two-Hybrid	NULL
System	NULL
.	NULL

Oxford	NULL
University	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

Bartel	NULL
,	NULL
PL	NULL
.	NULL

,	NULL
Chien	NULL
,	NULL
C.T	NULL
.	NULL

,	NULL
Sternglanz	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Field	NULL
,	NULL
S8	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Using	NULL
the	NULL
two-hybrid	NULL
system	NULL
to	NULL
detect	NULL
protein-protein	NULL
interaction	NULL
.	NULL

In	NULL
Cellular	NULL
Interactions	NULL
in	NULL
Development	NULL
:	NULL
A	NULL
Practical	NULL
Approach	NULL
.	NULL

Oxford	NULL
University	NULL
Press	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
,	NULL
pp	NULL
.	NULL

153-179	NULL
.	NULL

Baumon	NULL
,	NULL
L.E	NULL
.	NULL

,	NULL
Cazenave	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Srthou	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Anti-immunoglobulins	NULL
induce	NULL
death	NULL
by	NULL
apoptosis	NULL
in	NULL
WEHI-231	NULL
B	NULL
lymphoma	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
20	NULL
,	NULL
1405-1407	NULL
.	NULL

Boguski	NULL
,	NULL
M.S	NULL
.	NULL

and	NULL
McCormick	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proteins	NULL
regulating	NULL
Ras	NULL
and	NULL
its	NULL
relatives	NULL
.	NULL

Nature	NULL
,	NULL
366	NULL
,	NULL
643-654	NULL
.	NULL

Broome	NULL
,	NULL
H.E	NULL
.	NULL

,	NULL
Dargan	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Bressent	NULL
,	NULL
E.F.	NULL
,	NULL
Krajewski	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Reed	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Apoptosis	NULL
and	NULL
Bcl-2	NULL
expression	NULL
in	NULL
cultured	NULL
murine	NULL
splenic	NULL
T	NULL
cells	NULL
.	NULL

Immunology	NULL
,	NULL
84	NULL
,	NULL
375-381	NULL
.	NULL

Chao	NULL
,	NULL
D.T	NULL
.	NULL

and	NULL
Korsmeyer	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Bel-2	NULL
family	NULL
:	NULL
regulator	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
395-419	NULL
.	NULL

Chen	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Faller	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Phosphorylation	NULL
of	NULL
Bel-2	NULL
protein	NULL
and	NULL
association	NULL
with	NULL
p21	NULL
Ras	NULL
in	NULL
Ras-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
2376-2379	NULL
.	NULL

Chen	NULL
,	NULL
H.M	NULL
.	NULL

and	NULL
Boxer	NULL
,	NULL
L.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
P1	NULL
binding	NULL
sites	NULL
are	NULL
negative	NULL
regulators	NULL
of	NULL
be/-2	NULL
expression	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
3840-3847	NULL
.	NULL

di-Jeso	NULL
,	NULL
B.	NULL
,	NULL
-	NULL
Ulianich	NULL
,	NULL
L.	NULL
,	NULL
Racioppi	NULL
,	NULL
L.	NULL
,	NULL
D'Armiento	NULL
,	NULL
F	NULL
,	NULL
Feliciello	NULL
,	NULL
A.	NULL
,	NULL
Pacifico	NULL
,	NULL
F.	NULL
,	NULL
Consiglio	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Formisano	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Serum	NULL
withdrawal	NULL
induces	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
K-ras	NULL
transformed	NULL
but	NULL
not	NULL
in	NULL
normal	NULL
differentiated	NULL
thyroid	NULL
cells	NULL
.	NULL

Biockem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
214	NULL
,	NULL
819-824	NULL
.	NULL

Dobrowolski	NULL
,	NULL
S.	NULL
,	NULL
Harte	NULL
,	NULL
M.	NULL
and	NULL
Staicy	NULL
,	NULL
D.W	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cellular	NULL
Ras	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
passage	NULL
through	NULL
multiple	NULL
points	NULL
of	NULL
the	NULL
Gy-G	NULL
;	NULL
phase	NULL
in	NULL
BALB-c	NULL
3T3	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
5441-5449	NULL
.	NULL

Duke	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Cohen	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
IL-2	NULL
addition	NULL
:	NULL
withdrawal	NULL
of	NULL
growth	NULL
factor	NULL
activates	NULL
a	NULL
suicide	NULL
progamm	NULL
in	NULL
dependent	NULL
T	NULL
cells	NULL
.	NULL

Lymphokine	NULL
Res	NULL
.	NULL

,	NULL
5	NULL
,	NULL
289-299	NULL
.	NULL

Fairbaimm	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Cowling	NULL
,	NULL
G.J	NULL
.	NULL

,	NULL
Reipert	NULL
,	NULL
B.M	NULL
.	NULL

and	NULL
Dexter	NULL
,	NULL
L.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Suppression	NULL
of	NULL
apoptosis	NULL
allows	NULL
differentiation	NULL
and	NULL
development	NULL
of	NULL
multipotent	NULL
hematopoietic	NULL
cell	NULL
line	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
added	NULL
growth	NULL
factors	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
,	NULL
823-832	NULL
.	NULL

Fernandez-Sarabia	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Bischoff	NULL
,	NULL
J.R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Bel-2	NULL
associates	NULL
with	NULL
the	NULL
Ras-related	NULL
protein	NULL
R-Ras	NULL
p23	NULL
.	NULL

Nature	NULL
,	NULL
366	NULL
,	NULL
274-275	NULL
.	NULL

Ferrari	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
L.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proliferative	NULL
inhibition	NULL
by	NULL
dominant	NULL
Ras	NULL
and	NULL
Aiolos	NULL
interaction	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
negative	NULL
Ras	NULL
rescues	NULL
naive	NULL
and	NULL
neuronally	NULL
differentiated	NULL
PC12	NULL
cells	NULL
from	NULL
apoptotic	NULL
death	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
5922-5928	NULL
.	NULL

Fields	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Song,0.K	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
A	NULL
novel	NULL
genetic	NULL
system	NULL
to	NULL
detect	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Nature	NULL
,	NULL
340	NULL
,	NULL
245-246	NULL
.	NULL

Frampton	NULL
,	NULL
J.	NULL
,	NULL
Ramqvist	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
V-Myc	NULL
of	NULL
E26	NULL
leukemia	NULL
virus	NULL
upregulates	NULL
Bcl-2	NULL
expression	NULL
and	NULL
suppresses	NULL
apoptosis	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
2720-2731	NULL
.	NULL

Gomez	NULL
,	NULL
J.	NULL
,	NULL
Martinez-A	NULL
,	NULL
C.	NULL
,	NULL
Fernandez	NULL
,	NULL
B.	NULL
,	NULL
Garcia	NULL
,	NULL
A.	NULL
and	NULL
Rebollo	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Critical	NULL
role	NULL
for	NULL
Ras	NULL
the	NULL
proliferation	NULL
and	NULL
prevention	NULL
of	NULL
apoptosis	NULL
mediated	NULL
by	NULL
IL-2	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
157	NULL
,	NULL
2772-2781	NULL
.	NULL

Gomez	NULL
,	NULL
J.	NULL
,	NULL
Martinez-A	NULL
,	NULL
C.	NULL
,	NULL
Fernandez	NULL
,	NULL
B.	NULL
,	NULL
Garcia	NULL
,	NULL
A.	NULL
and	NULL
Rebollo	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Ras	NULL
activation	NULL
leads	NULL
to	NULL
cell	NULL
proliferation	NULL
or	NULL
apoptotic	NULL
cell	NULL
death	NULL
on	NULL
IL-2-stimulated	NULL
or	NULL
lymphokine-deprivation	NULL
,	NULL
respectively	NULL
.	NULL

Eur	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
27	NULL
,	NULL
1610-1618	NULL
.	NULL

Gomez	NULL
,	NULL
J.	NULL
,	NULL
Martinez-A	NULL
,	NULL
C.	NULL
,	NULL
Gonzélez	NULL
,	NULL
A.	NULL
,	NULL
Garcia	NULL
,	NULL
A.	NULL
and	NULL
Rebollo	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998a	NULL
)	NULL
The	NULL
Bcel-2	NULL
gene	NULL
is	NULL
differentially	NULL
regulated	NULL
by	NULL
IL-2	NULL
and	NULL
IL-4	NULL
:	NULL
role	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-AT	NULL
.	NULL

Oncogene	NULL
,	NULL
17	NULL
,	NULL
1235-1243	NULL
.	NULL

Gomez	NULL
,	NULL
J.	NULL
,	NULL
Martinez-A	NULL
,	NULL
C.	NULL
,	NULL
Gonzdlez	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Rebollo	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998b	NULL
)	NULL
Dual	NULL
role	NULL
of	NULL
Ras	NULL
and	NULL
Rho	NULL
proteins	NULL
:	NULL
at	NULL
the	NULL
cutting	NULL
edge	NULL
of	NULL
life	NULL
and	NULL
death	NULL
.	NULL

Immunol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
76	NULL
,	NULL
125-134	NULL
.	NULL

Gratiot-Deans	NULL
,	NULL
J.	NULL
,	NULL
Ding	NULL
,	NULL
L.	NULL
,	NULL
Turka	NULL
,	NULL
L.A	NULL
.	NULL

and	NULL
Nufiez	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Bei-2	NULL
proto-oncogene	NULL
expression	NULL
during	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Evidence	NULL
for	NULL
biphasic	NULL
regulation	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
151	NULL
,	NULL
83-91	NULL
.	NULL

Gulbins	NULL
,	NULL
E.	NULL
,	NULL
Bissonnette	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Mahbouhi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Fas-induced	NULL
apoptosis	NULL
is	NULL
mediated	NULL
via	NULL
ceramide-initiated	NULL
Ras	NULL
signaling	NULL
pathway	NULL
.	NULL

Immunity	NULL
,	NULL
2	NULL
,	NULL
341-351	NULL
.	NULL

Hannon	NULL
,	NULL
G.J	NULL
.	NULL

,	NULL
Demeftrick	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Beach	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Isolation	NULL
of	NULL
the	NULL
Rb-related	NULL
p130	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
CDK2	NULL
and	NULL
cyclins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
2378-2391	NULL
.	NULL

Heckman	NULL
,	NULL
C.	NULL
,	NULL
Mochon	NULL
,	NULL
E.	NULL
,	NULL
Arcinas	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Boxer	NULL
,	NULL
L.M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
WT	NULL
1	NULL
protein	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
the	NULL
normal	NULL
Bei-2	NULL
allele	NULL
in	NULL
lymphomas	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
,	NULL
19609-19614	NULL
.	NULL

Hewitt	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
_	NULL
Hamada	NULL
,	NULL
S.	NULL
,	NULL
-	NULL
McDonnelL	NULL
,	NULL
T.J.	NULL
,	NULL
-	NULL
Rauscher	NULL
,	NULL
FJ	NULL
.	NULL

-	NULL
and	NULL
Saunders	NULL
,	NULL
G.F	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Differential	NULL
spliced	NULL
exon	NULL
5	NULL
of	NULL
the	NULL
Wilm	NULL
's	NULL
tumor	NULL
gene	NULL
WTI	NULL
modifies	NULL
gene	NULL
function	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
55	NULL
,	NULL
5386-5389	NULL
.	NULL

Kinoshita	NULL
,	NULL
T.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Arai	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Regulation	NULL
of	NULL
Bcl-2	NULL
expression	NULL
by	NULL
oncogenic	NULL
ras	NULL
protein	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
,	NULL
2207-2212	NULL
.	NULL

Lai	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
Bogulski	NULL
,	NULL
M.	NULL
,	NULL
Broek	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Powers	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Influence	NULL
of	NULL
guanine	NULL
nucleotides	NULL
complex	NULL
formation	NULL
between	NULL
Ras	NULL
and	NULL
CDC25	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
1345-1352	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Frisch	NULL
,	NULL
E.F	NULL
.	NULL

and	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

2nd	NULL
edn	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

McCormick	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Going	NULL
for	NULL
the	NULL
GAP	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
673-674	NULL
.	NULL

Minami	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Taniguchi	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
IL-2	NULL
signaling	NULL
:	NULL
recruitment	NULL
and	NULL
activation	NULL
of	NULL
multiple	NULL
protenin	NULL
tyrosine	NULL
kinases	NULL
by	NULL
components	NULL
of	NULL
the	NULL
IL-2R	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
156-162	NULL
.	NULL

Miyashita	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Reed	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Tumor	NULL
suppressor	NULL
p53	NULL
is	NULL
a	NULL
direct	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
human	NULL
bax	NULL
gene	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
,	NULL
293-299	NULL
.	NULL

Miyashita	NULL
,	NULL
T.	NULL
,	NULL
Harigai	NULL
,	NULL
M.	NULL
,	NULL
Hanada	NULL
,	NULL
M.	NULL
and	NULL
Reed	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Identification	NULL
of	NULL
p53-dependent	NULL
negative	NULL
response	NULL
element	NULL
in	NULL
the	NULL
Bci-2	NULL
gene	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
54	NULL
,	NULL
3131-3135	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
Liu	NULL
,	NULL
Z.J	NULL
.	NULL

,	NULL
Kawajar	NULL
,	NULL
A.	NULL
,	NULL
Minami	NULL
,	NULL
Y.	NULL
,	NULL
Yamada	NULL
,	NULL
K.	NULL
,	NULL
Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
Barsouimian	NULL
,	NULL
L.	NULL
,	NULL
Pelmutter	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Taniguchi	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Three	NULL
distinct	NULL
IL-2	NULL
signaling	NULL
pathways	NULL
mediated	NULL
by	NULL
Bel-2	NULL
,	NULL
c-Myc	NULL
and	NULL
Lck	NULL
cooperate	NULL
in	NULL
hemapoietic	NULL
cell	NULL
proliferation	NULL
.	NULL

Cell	NULL
,	NULL
81	NULL
,	NULL
223-231	NULL
.	NULL

Morgan	NULL
,	NULL
B.	NULL
,	NULL
Sun	NULL
,	NULL
L.	NULL
,	NULL
Avitahl	NULL
,	NULL
N.	NULL
,	NULL
Andrikopoulus	NULL
,	NULL
K.	NULL
,	NULL
Ikeda	NULL
,	NULL
T.	NULL
,	NULL
Gonzales	NULL
,	NULL
E.	NULL
,	NULL
Wu	NULL
,	NULL
P.	NULL
,	NULL
Neben	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Georgopoulus	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Aiolos	NULL
,	NULL
a	NULL
lymphoid	NULL
restricted	NULL
transcription	NULL
factor	NULL
that	NULL
interacts	NULL
with	NULL
Ikaros	NULL
to	NULL
regulate	NULL
lymphocyte	NULL
differentiation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
2004-2013	NULL
.	NULL

Nagata	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Apoptosis	NULL
by	NULL
death	NULL
factors	NULL
.	NULL

Cell	NULL
,	NULL
88	NULL
,	NULL
355-365	NULL
.	NULL

Nufiez	NULL
,	NULL
G.	NULL
,	NULL
London	NULL
,	NULL
L.	NULL
,	NULL
Hockenbery	NULL
,	NULL
D.	NULL
,	NULL
Alexander	NULL
,	NULL
M.	NULL
,	NULL
McDearn	NULL
,	NULL
J.P	NULL
.	NULL

and	NULL
Korsmeyer	NULL
,	NULL
S.J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Deregulated	NULL
Bci-2	NULL
gene	NULL
expression	NULL
selectively	NULL
prolongs	NULL
survival	NULL
of	NULL
growth	NULL
factor-deprived	NULL
hemopoietic	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
144	NULL
,	NULL
3602-3610	NULL
.	NULL

Pan	NULL
,	NULL
B.T	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
C.T	NULL
.	NULL

and	NULL
Lin	NULL
,	NULL
S.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Oncogenic	NULL
Ras	NULL
blocks	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
inhibits	NULL
p34	NULL
cdc2	NULL
kinase	NULL
in	NULL
activated	NULL
Xenopus	NULL
egg	NULL
extracts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
5968-5975	NULL
.	NULL

Park	NULL
,	NULL
J.R	NULL
.	NULL

and	NULL
Hockenbery	NULL
,	NULL
D.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Bel-2	NULL
,	NULL
a	NULL
novel	NULL
regulator	NULL
of	NULL
apoptosis	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
60	NULL
,	NULL
12-17	NULL
.	NULL

Pitton	NULL
,	NULL
C.	NULL
,	NULL
Rebollo	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
Theze	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Garcia	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
High	NULL
affinity	NULL
and	NULL
intermediate	NULL
affinity	NULL
forms	NULL
of	NULL
the	NULL
human	NULL
IL-2R	NULL
,	NULL
expressed	NULL
in	NULL
an	NULL
IL-9-dependent	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
deliver	NULL
proliferative	NULL
signals	NULL
via	NULL
differences	NULL
in	NULL
their	NULL
transduction	NULL
pathways	NULL
.	NULL

Cytokine	NULL
,	NULL
5	NULL
,	NULL
362-371	NULL
.	NULL

Reed	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Bel-2	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
124	NULL
,	NULL
1-6	NULL
.	NULL

3429	NULL
FRomero	NULL
et	NULL
al	NULL
.	NULL

Smith	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Williams	NULL
,	NULL
G.T	NULL
.	NULL

,	NULL
Kingston	NULL
,	NULL
R.	NULL
,	NULL
Jenkinson	NULL
,	NULL
E.J	NULL
.	NULL

and	NULL
Owen	NULL
,	NULL
J.T	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Antibodies	NULL
to	NULL
CD3/T	NULL
cell	NULL
receptor	NULL
complex	NULL
induce	NULL
cell	NULL
death	NULL
by	NULL
apoptosis	NULL
in	NULL
immature	NULL
T	NULL
cell	NULL
in	NULL
thymic	NULL
culture	NULL
.	NULL

Nature	NULL
,	NULL
337	NULL
,	NULL
181-184	NULL
.	NULL

Smith	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Ensor	NULL
,	NULL
E.A	NULL
.	NULL

,	NULL
Coffin	NULL
,	NULL
R.S	NULL
.	NULL

,	NULL
Boxer	NULL
,	NULL
L.M	NULL
.	NULL

and	NULL
Latchman	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Bel-2	NULL
transcription	NULL
from	NULL
the	NULL
proximal	NULL
P2	NULL
promoter	NULL
is	NULL
activated	NULL
in	NULL
neuronal	NULL
cells	NULL
by	NULL
the	NULL
Bm-3a	NULL
POU	NULL
family	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
16715-16722	NULL
.	NULL

Taylor	NULL
,	NULL
D.	NULL
,	NULL
Badiani	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Weston	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
A	NULL
dominant	NULL
interferin	NULL
Myb	NULL
mutant	NULL
causes	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
2732-2744	NULL
.	NULL

Taylor	NULL
,	NULL
S.J	NULL
.	NULL

and	NULL
Shalloway	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
cycle-dependent	NULL
activation	NULL
of	NULL
Ras	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1621-1627	NULL
.	NULL

Veis	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Sentman	NULL
,	NULL
C.L	NULL
.	NULL

,	NULL
Bach	NULL
,	NULL
E.A	NULL
.	NULL

and	NULL
Korsmeyer	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
Bel-2	NULL
protein	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
thymocytes	NULL
and	NULL
in	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
151	NULL
,	NULL
2546-2554	NULL
.	NULL

Vojtek	NULL
,	NULL
A.	NULL
,	NULL
Hollenberg	NULL
,	NULL
S.M	NULL
.	NULL

and	NULL
Cooper	NULL
,	NULL
J.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mammalian	NULL
Ras	NULL
interacts	NULL
directly	NULL
with	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
Raf	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
,	NULL
205-241	NULL
.	NULL

Wang	NULL
,	NULL
H.G	NULL
.	NULL

,	NULL
Millan	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Cox	NULL
,	NULL
A.D.	NULL
,	NULL
Der	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
Rapp	NULL
,	NULL
U.R	NULL
.	NULL

,	NULL
Beck	NULL
,	NULL
T.	NULL
,	NULL
Zha	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Reed	NULL
,	NULL
J.C.	NULL
(	NULL
1995	NULL
)	NULL
R-Ras	NULL
promotes	NULL
apoptosis	NULL
caused	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
via	NULL
Bcl-2	NULL
suppressible	NULL
mechanism	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
129	NULL
,	NULL
1103-1114	NULL
.	NULL

Wang	NULL
,	NULL
J.H	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Aiolos	NULL
regulates	NULL
B	NULL
cell	NULL
activation	NULL
and	NULL
maturation	NULL
to	NULL
effector	NULL
stage	NULL
.	NULL

Immunity	NULL
,	NULL
9	NULL
,	NULL
543-553	NULL
.	NULL

White	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Life	NULL
,	NULL
death	NULL
and	NULL
the	NULL
pursuit	NULL
of	NULL
apoptosis	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
1-15	NULL
.	NULL

Williams	NULL
,	NULL
G.T	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Spooncer	NULL
,	NULL
E.	NULL
,	NULL
Drexter	NULL
,	NULL
T.M	NULL
.	NULL

and	NULL
Taylor	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Haematopoietic	NULL
colony-stimulating	NULL
factor	NULL
promotes	NULL
cell	NULL
survival	NULL
by	NULL
suppressing	NULL
apoptosis	NULL
.	NULL

Nature	NULL
,	NULL
343	NULL
,	NULL
76-79	NULL
.	NULL

Wilson	NULL
,	NULL
B.E	NULL
.	NULL

,	NULL
Mochon	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Boxen	NULL
,	NULL
L.B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Induction	NULL
of	NULL
Bcl-2	NULL
expression	NULL
by	NULL
phosphorylated	NULL
CREB	NULL
protein	NULL
during	NULL
B	NULL
cell	NULL
activation	NULL
and	NULL
rescue	NULL
from	NULL
apoptosis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
5546-5556	NULL
.	NULL

Wilson	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Fortner	NULL
,	NULL
K.A	NULL
.	NULL

and	NULL
Lynch	NULL
,	NULL
D.H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
JNK	NULL
,	NULL
but	NULL
not	NULL
MAPK	NULL
,	NULL
activation	NULL
is	NULL
associated	NULL
with	NULL
Fas-mediated	NULL
apoptosis	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
26	NULL
,	NULL
989-994	NULL
.	NULL

Winston	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
Coats	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
Y.Z	NULL
.	NULL

and	NULL
Pledger	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Regulation	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
machinery	NULL
by	NULL
oncogenic	NULL
Ras	NULL
.	NULL

Oncogene	NULL
,	NULL
12	NULL
,	NULL
127-134	NULL
.	NULL

Wyllie	NULL
,	NULL
A.H.	NULL
(	NULL
1980	NULL
)	NULL
Glucocorticoid-induced	NULL
thymocyte	NULL
apoptosis	NULL
is	NULL
associated	NULL
with	NULL
endogenous	NULL
nuclease	NULL
activation	NULL
.	NULL

Nature	NULL
,	NULL
284	NULL
,	NULL
555-556	NULL
.	NULL

Yang	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Korsmeyer	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Molecular	NULL
thanatopsis	NULL
:	NULL
a	NULL
discourse	NULL
on	NULL
the	NULL
Bcl-2	NULL
family	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
,	NULL
386-402	NULL
.	NULL

Young	NULL
,	NULL
R.L	NULL
.	NULL

and	NULL
Korsmeyer	NULL
,	NULL
S.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
A	NULL
negaitve	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
Bcl-2	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
inhibits	NULL
expression	NULL
from	NULL
an	NULL
upstream	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
3683-3697	NULL
.	NULL

Zubiaga	NULL
,	NULL
A.M.	NULL
,	NULL
Mufioz	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Huber	NULL
,	NULL
B.T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
IL-2	NULL
and	NULL
IL-4	NULL
selectively	NULL
rescue	NULL
Th	NULL
cells	NULL
subsets	NULL
from	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
149	NULL
,	NULL
107-112	NULL
.	NULL

Received	NULL
February	NULL
1	NULL
,	NULL
1999	NULL
;	NULL
revised	NULL
April	NULL
13	NULL
,	NULL
1999	NULL
;	NULL
accepted	NULL
April	NULL
26	NULL
,	NULL
1999	NULL
3430	NULL

